- 2024.12.23
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated cytarabine Injection, solution 100 mg Current Limited Availability Unexpected increase in consumer demand 20/12/2024 topiramate Tablet, film coated 25 mg Resolved Available Manufacturing 20/12/2024 topiramate Tablet, film coated 100 mg Current Unavailable Manufacturing 20/12/2024 topiramate Tablet, film coated 200 mg Current Unavailable Manufacturing 20/12/2024 heparin sodium Injection, solution 5000 IU/mL Current Limited Availability Unexpected increase in consumer demand 20/12/2024 fentanyl Drug delivery system, transdermal 16.8 mg Current Limited Availability Manufacturing 20/12/2024 olanzapine Tablet, orally disintegrating 20 mg Current Limited Availability Manufacturing 20/12/2024 levetiracetam Tablet, film coated 250 mg Resolved Available Transport / Logistic issues / Storage capacity issues 20/12/2024 doxorubicin hydrochloride Injection, concentrated 2 mg/mL Current Limited Availability Manufacturing 20/12/2024 trandolapril Capsule, hard 1 mg Current Limited Availability Manufacturing 20/12/2024 olmesartan medoxomil Tablet, film coated 40 mg Current Unavailable Manufacturing 20/12/2024 simvastatin Tablet, film coated 40 mg Resolved Available Manufacturing 20/12/2024 codeine phosphate hemihydrate~ibuprofen Tablet, film coated 12.8 mg~200 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 20/12/2024 voriconazole Injection, powder for 200 mg Current Unavailable Manufacturing 20/12/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 20/12/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 20/12/2024 dasatinib Tablet, film coated 20 mg Anticipated Available Unexpected increase in consumer demand 20/12/2024 fenofibrate Tablet 145 mg Anticipated Available Manufacturing 20/12/2024 teriflunomide Tablet, film coated 14 mg Current Unavailable Manufacturing 20/12/2024 latanoprost~timolol maleate Eye Drops, solution .05 mg/mL~6.83 mg/mL Current Unavailable Manufacturing 20/12/2024 hydrochlorothiazide~olmesartan medoxomil~amlodipine besilate Tablet, film coated 25 mg~40 mg~6.95 mg Resolved Available Manufacturing 20/12/2024 gentamicin sulfate Injection, solution 135.6 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 20/12/2024 sodium amidotrizoate~amidotrizoate meglumine Injection, solution 40 mg/mL~260 mg/mL Current Unavailable Manufacturing 20/12/2024 fluorouracil Injection, solution 50 mg/mL Current Limited Availability Manufacturing 20/12/2024 oxycodone hydrochloride Oral Liquid, solution 1 mg/mL Resolved Available Unexpected increase in consumer demand 20/12/2024 methylphenidate hydrochloride Capsule, modified release 40 mg Resolved Available Transport / Logistic issues / Storage capacity issues 20/12/2024 methylphenidate hydrochloride Tablet, modified release 27 mg Current Limited Availability Manufacturing 19/12/2024 tazobactam sodium~piperacillin sodium Injection, powder for .54 g~4.2 g Discontinued Unavailable Unexpected increase in consumer demand 19/12/2024 fentanyl Drug delivery system, transdermal 12.6 mg Anticipated Available Manufacturing 19/12/2024 midazolam Injection, solution 5 mg Current Limited Availability Manufacturing 19/12/2024 diazepam Tablet, uncoated 2 mg Resolved Available Manufacturing 19/12/2024 azithromycin Injection, powder for 500 mg Current Unavailable Commercial Changes / Commercial viability 19/12/2024 trandolapril Capsule, hard .5 mg Current Unavailable Manufacturing 19/12/2024 trandolapril Capsule, hard 2 mg Current Unavailable Manufacturing 19/12/2024 trandolapril Capsule, hard 4 mg Current Unavailable Manufacturing 19/12/2024 quetiapine fumarate Tablet, film coated 28.78 mg Current Unavailable Manufacturing 19/12/2024 tobramycin Injection, solution 40 mg/mL Current Limited Availability Unexpected increase in consumer demand 19/12/2024 emtricitabine~tenofovir disoproxil maleate Tablet, film coated 200 mg~300 mg Current Unavailable Manufacturing 19/12/2024 cinacalcet hydrochloride Tablet 99.191 mg Current Limited Availability Manufacturing 19/12/2024 lorazepam Tablet 2.5 mg Resolved Available Manufacturing 19/12/2024 tenofovir disoproxil succinate~emtricitabine Tablet, film coated 300.6 mg~200 mg Current Unavailable Manufacturing 19/12/2024 rosuvastatin calcium Tablet, film coated 20.84 mg Current Limited Availability Manufacturing 19/12/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 19/12/2024 cefaclor monohydrate Oral Liquid, powder for 52.45 mg/mL Resolved Available Unexpected increase in consumer demand 19/12/2024 dostarlimab Injection, intravenous infusion 500 mg/mL Resolved Available Unexpected increase in consumer demand 19/12/2024 cisplatin Injection, solution 1 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 19/12/2024 citalopram hydrobromide Tablet, film coated 24.98 mg Anticipated Available Manufacturing 19/12/2024 pravastatin sodium Tablet, uncoated 40 mg Current Unavailable Manufacturing 19/12/2024 clarithromycin Tablet, film coated 250 mg Current Unavailable Unexpected increase in consumer demand 19/12/2024 moclobemide Tablet, film coated 150 mg Resolved Available Manufacturing 19/12/2024 bupivacaine hydrochloride monohydrate Injection, solution 52.7 mg Current Unavailable Unexpected increase in consumer demand 18/12/2024 sildenafil citrate Tablet, film coated 28.09 mg Current Unavailable Unexpected increase in consumer demand 18/12/2024 sumatriptan succinate Tablet, film coated 140 mg Current Unavailable Manufacturing 18/12/2024 tranexamic acid Injection, solution 1000 mg Anticipated Available Manufacturing 18/12/2024 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 18/12/2024 efmoroctocog alfa Injection, powder for 250 IU Resolved Available Unexpected increase in consumer demand 18/12/2024 paroxetine hydrochloride Tablet, film coated 22.21 mg Anticipated Available Manufacturing 18/12/2024 buprenorphine Drug delivery system, transdermal 5 mg Current Limited Availability Manufacturing 18/12/2024 mesalazine Tablet, enteric coated 800 mg Anticipated Available Manufacturing 18/12/2024 mesalazine Tablet, enteric coated 1.6 g Anticipated Available Manufacturing 18/12/2024 Fremanezumab Injection, solution 225 mg Current Limited Availability Unexpected increase in consumer demand 18/12/2024 clonazepam Tablet, uncoated .5 mg Resolved Available Manufacturing 18/12/2024 estradiol hemihydrate Drug delivery system, transdermal 1.54 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 18/12/2024 estradiol hemihydrate Drug delivery system, transdermal .77 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 18/12/2024 estradiol hemihydrate Drug delivery system, transdermal 3.09 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 18/12/2024 estradiol hemihydrate Drug delivery system, transdermal 2.32 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 18/12/2024 methylphenidate hydrochloride Capsule, modified release 30 mg Anticipated Available Manufacturing 18/12/2024 terbinafine hydrochloride Tablet, uncoated 281.3 mg Resolved Available Manufacturing 17/12/2024 isosorbide dinitrate Tablet, uncoated 5 mg Resolved Available Manufacturing 17/12/2024 fluorouracil Injection, solution 5000 mg Anticipated Available Unexpected increase in consumer demand 17/12/2024 acetylcysteine Injection, concentrated 2 g Current Unavailable Transport / Logistic issues / Storage capacity issues 17/12/2024 olmesartan medoxomil~amlodipine besilate~hydrochlorothiazide Tablet 40 mg~6.944 mg~25 mg Current Limited Availability Manufacturing 17/12/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 17/12/2024 quetiapine fumarate Tablet, film coated 28.78 mg Current Unavailable Manufacturing 17/12/2024 midazolam Injection, solution 5 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 17/12/2024 midazolam Injection, solution 5 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 17/12/2024 rizatriptan benzoate Tablet, orally disintegrating 14.53 mg Current Limited Availability Manufacturing 17/12/2024 prilocaine hydrochloride~felypressin Injection, solution 30 mg/mL~.54 microgram/mL Anticipated Available Manufacturing 17/12/2024 temozolomide Capsule, hard 5 mg Resolved Available Manufacturing 17/12/2024 temozolomide Capsule, hard 20 mg Resolved Available Manufacturing 17/12/2024 temozolomide Capsule, hard 100 mg Resolved Available Transport / Logistic issues / Storage capacity issues 17/12/2024 rosuvastatin calcium Tablet, film coated 10.42 mg Resolved Available Manufacturing 17/12/2024 citalopram hydrobromide Tablet, film coated 49.98 mg Current Limited Availability Manufacturing 17/12/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 17/12/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 17/12/2024 gemeprost Pessary 1 mg Discontinued Reduction in supply until supply is exhausted Manufacturing 17/12/2024 tenofovir disoproxil fumarate~emtricitabine Tablet, film coated 300 mg~200 mg Anticipated Available Manufacturing 17/12/2024 fluorouracil Injection, solution 50 mg/mL Current Limited Availability Manufacturing 17/12/2024 betahistine dihydrochloride Tablet, uncoated 16 mg Resolved Available Manufacturing 17/12/2024 timolol maleate Eye Drops, solution 6.83 mg/mL Current Unavailable Commercial Changes / Commercial viability 17/12/2024 lacosamide Tablet, film coated 50 mg Resolved Available Manufacturing 17/12/2024 pregabalin Capsule, hard 25 mg Current Limited Availability Manufacturing 17/12/2024 Semaglutide Injection, solution 1.34 mg/mL Current Limited Availability Unexpected increase in consumer demand 17/12/2024 Semaglutide Injection, solution 1.34 mg/mL Current Limited Availability Unexpected increase in consumer demand 17/12/2024 olanzapine Tablet, uncoated 2.5 mg Current Unavailable Manufacturing 17/12/2024 methotrexate Tablet 2.5 mg Anticipated Available Manufacturing 17/12/2024 timolol maleate Eye Drops, solution 6.84 mg/mL Current Unavailable Manufacturing 17/12/2024 dorzolamide hydrochloride Eye Drops, solution 22.26 mg/mL Current Unavailable Manufacturing 17/12/2024 clindamycin phosphate Lotion 10 mg/mL Current Unavailable Manufacturing 17/12/2024 famotidine Tablet, film coated 20 mg Current Unavailable Manufacturing 17/12/2024 methylphenidate hydrochloride Tablet, modified release 36 mg Current Limited Availability Manufacturing 17/12/2024 risperidone Tablet, film coated 2 mg Current Limited Availability Unexpected increase in consumer demand 16/12/2024 carboplatin Injection, solution 450 mg Current Limited Availability Manufacturing 16/12/2024 bosentan monohydrate Tablet, film coated 129.08 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 16/12/2024 mesalazine Tablet, enteric coated 250 mg Anticipated Available Manufacturing 16/12/2024 rasagiline mesilate Tablet 1.56 mg Resolved Available Manufacturing 16/12/2024 lacosamide Tablet, film coated 150 mg Resolved Available Transport / Logistic issues / Storage capacity issues 16/12/2024 isavuconazonium sulfate Capsule 186.3 mg Resolved Available Unexpected increase in consumer demand 16/12/2024 furosemide Injection, solution 10 mg/mL Current Limited Availability Transport / Logistic issues / Storage capacity issues 16/12/2024 thiotepa Injection, powder for 15 mg Current Limited Availability Unexpected increase in consumer demand 16/12/2024 levothyroxine sodium Tablet 50 microgram Current Unavailable Manufacturing 16/12/2024 nizatidine Capsule 150 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 16/12/2024 nizatidine Capsule 300 mg Current Limited Availability Manufacturing 16/12/2024 - 2024.12.16
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated tramadol hydrochloride Tablet, modified release 200 mg Current Limited Availability Manufacturing 13/12/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 13/12/2024 entecavir Tablet, film coated .5 mg Current Limited Availability Manufacturing 13/12/2024 prilocaine hydrochloride~felypressin Injection, solution 30 mg/mL~.54 microgram/mL Anticipated Available Manufacturing 13/12/2024 tranexamic acid Injection, solution 1000 mg Current Limited Availability Commercial Changes / Commercial viability 13/12/2024 morphine hydrochloride trihydrate Injection, solution 20 mg/mL Anticipated Available Manufacturing 13/12/2024 ramucirumab Injection, intravenous infusion 100 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 13/12/2024 codeine phosphate hemihydrate~ibuprofen Tablet, film coated 12.8 mg~200 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 13/12/2024 esomeprazole Capsule, enteric 20 mg Anticipated Available Manufacturing 13/12/2024 encorafenib Capsule, hard 75 mg Current Limited Availability Manufacturing 13/12/2024 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Anticipated Available Manufacturing 13/12/2024 atorvastatin calcium trihydrate Tablet, film coated 43.376 mg Anticipated Available Manufacturing 13/12/2024 pegcetacoplan Injection, solution 1080 mg Current Limited Availability Manufacturing 13/12/2024 rifabutin Capsule, hard 150 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 13/12/2024 doxycycline hyclate Tablet, film coated 57.5 mg Anticipated Available Manufacturing 13/12/2024 olanzapine Injection, powder for 10 mg Current Limited Availability Unexpected increase in consumer demand 13/12/2024 moclobemide Tablet, film coated 150 mg Current Limited Availability Manufacturing 13/12/2024 acetylcholine chloride Solution, powder for irrigation 10 mg/mL Current Unavailable Manufacturing 12/12/2024 ramipril Capsule, hard 1.25 mg Current Limited Availability Manufacturing 12/12/2024 ibuprofen~codeine phosphate hemihydrate Tablet, film coated 200 mg~12.8 mg Discontinued Unavailable Transport / Logistic issues / Storage capacity issues 12/12/2024 mirtazapine Tablet, film coated 45 mg Current Limited Availability Manufacturing 12/12/2024 Somatropin Injection, powder for 12 mg/mL Resolved Available Transport / Logistic issues / Storage capacity issues 12/12/2024 risperidone Tablet, film coated 1 mg Current Limited Availability Unexpected increase in consumer demand 12/12/2024 duloxetine hydrochloride Capsule, enteric 67.32 mg Current Unavailable Commercial Changes / Commercial viability 12/12/2024 drospirenone~ethinylestradiol Tablet, film coated 3 mg~.03 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 12/12/2024 clonazepam Tablet, uncoated .5 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 12/12/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 12/12/2024 daptomycin Injection, powder for 500 mg Discontinued Unavailable Commercial Changes / Commercial viability 12/12/2024 tamoxifen citrate Tablet 30.34 mg Current Limited Availability Manufacturing 12/12/2024 sitagliptin hydrochloride monohydrate~metformin hydrochloride Tablet, modified release 113.37 mg~1000 mg Current Unavailable Manufacturing 12/12/2024 tamoxifen citrate Tablet, uncoated 15.2 mg Anticipated Available Manufacturing 12/12/2024 prazosin hydrochloride Tablet, uncoated 1.1 mg Current Unavailable Manufacturing 12/12/2024 prazosin hydrochloride Tablet, uncoated 2.2 mg Current Unavailable Manufacturing 12/12/2024 prazosin hydrochloride Tablet, uncoated 5.5 mg Current Unavailable Manufacturing 12/12/2024 nizatidine Capsule 300 mg Current Limited Availability Manufacturing 12/12/2024 nizatidine Capsule, hard 300 mg Anticipated Available Manufacturing 12/12/2024 flecainide acetate Injection, solution 10 mg/mL Current Unavailable Manufacturing 11/12/2024 methylphenidate hydrochloride Tablet, modified release 27 mg Anticipated Available Manufacturing 11/12/2024 fentanyl Drug delivery system, transdermal 8.4 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 11/12/2024 gabapentin Tablet, film coated 600 mg Resolved Available Manufacturing 11/12/2024 azithromycin dihydrate Tablet, film coated 524.1 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 11/12/2024 oxytocin Injection, solution 10 IU Current Unavailable Manufacturing 11/12/2024 cisatracurium besilate Injection, solution 13.4 mg Discontinued Unavailable Commercial Changes / Commercial viability 11/12/2024 simvastatin Tablet, film coated 10 mg Current Limited Availability Manufacturing 11/12/2024 simvastatin Tablet, film coated 80 mg Anticipated Available Manufacturing 11/12/2024 morphine hydrochloride trihydrate Injection, solution 10 mg/mL Anticipated Available Manufacturing 11/12/2024 tenofovir disoproxil maleate Tablet, film coated 300 mg Current Limited Availability Manufacturing 11/12/2024 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Unexpected increase in consumer demand 11/12/2024 nicotinic acid Tablet, uncoated 250 mg Current Unavailable Manufacturing 11/12/2024 ivabradine hydrochloride Tablet, film coated 8.085 mg Anticipated Available Manufacturing 11/12/2024 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~20.681 mg Current Unavailable Manufacturing 11/12/2024 dexmedetomidine hydrochloride Injection, concentrated 118 microgram/mL Current Limited Availability Manufacturing 11/12/2024 naloxone hydrochloride dihydrate Spray, nasal 2.2 mg/actuation Current Limited Availability Manufacturing 11/12/2024 aciclovir Injection, solution 25 mg/mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 11/12/2024 aciclovir Injection, solution 25 mg/mL Resolved Available Manufacturing 11/12/2024 temozolomide Capsule, hard 5 mg Resolved Available Manufacturing 11/12/2024 methylphenidate hydrochloride Tablet, modified release 54 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 11/12/2024 methylphenidate hydrochloride Tablet, modified release 18 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 11/12/2024 levothyroxine sodium Tablet, uncoated .2 mg Current Limited Availability Manufacturing 11/12/2024 tirzepatide Injection, solution 5 mg Current Unavailable Commercial Changes / Commercial viability 11/12/2024 metformin hydrochloride Tablet, film coated 850 mg Current Unavailable Manufacturing 11/12/2024 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Manufacturing 11/12/2024 methylphenidate hydrochloride Tablet, modified release 36 mg Anticipated Available Manufacturing 11/12/2024 lidocaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrate Injection, solution 21.3 mg/mL~22.7 microgram/mL Anticipated Available Manufacturing 10/12/2024 hydrocortisone acetate Eye Ointment 10 mg/g Current Unavailable Manufacturing 10/12/2024 morphine hydrochloride trihydrate Oral Liquid, solution 5 mg/mL Resolved Available Commercial Changes / Commercial viability 10/12/2024 losartan potassium Tablet, film coated 50 mg Current Limited Availability Manufacturing 10/12/2024 losartan potassium Tablet, film coated 25 mg Current Limited Availability Manufacturing 10/12/2024 heparin sodium Injection, solution 25000 IU/mL Anticipated Available Manufacturing 10/12/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Discontinued Unavailable Manufacturing 10/12/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Discontinued Unavailable Manufacturing 10/12/2024 duloxetine hydrochloride Capsule, enteric 33.66 mg Current Unavailable Unexpected increase in consumer demand 10/12/2024 efmoroctocog alfa Injection, powder for 250 IU Current Unavailable Unexpected increase in consumer demand 10/12/2024 candesartan cilexetil Tablet, uncoated 4 mg Current Limited Availability Manufacturing 10/12/2024 tranexamic acid Injection, solution 100 mg/mL Current Limited Availability Manufacturing 10/12/2024 azithromycin dihydrate Tablet, film coated 524 mg Current Limited Availability Manufacturing 10/12/2024 nizatidine Capsule, hard 150 mg Current Unavailable Manufacturing 10/12/2024 atorvastatin calcium trihydrate Tablet, film coated 86.76 mg Current Limited Availability Manufacturing 10/12/2024 tenofovir disoproxil fumarate Tablet 300 mg Resolved Available Manufacturing 10/12/2024 levetiracetam Tablet, film coated 1000 mg Resolved Available Manufacturing 10/12/2024 nebivolol hydrochloride Tablet 5.45 mg Resolved Available Manufacturing 10/12/2024 trimethoprim Tablet, uncoated 300 mg Current Limited Availability Manufacturing 10/12/2024 sitagliptin fumarate Tablet, film coated 32.124 mg Current Unavailable Manufacturing 10/12/2024 olmesartan medoxomil~amlodipine besilate Tablet, film coated 40 mg~13.88 mg Current Unavailable Manufacturing 10/12/2024 methylphenidate hydrochloride Tablet, modified release 36 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 10/12/2024 methylphenidate hydrochloride Tablet, modified release 27 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 10/12/2024 melatonin Capsule, hard 5 mg Current Limited Availability Unexpected increase in consumer demand 10/12/2024 melatonin Oral Liquid, solution 1 mg/mL Current Limited Availability Unexpected increase in consumer demand 10/12/2024 fosinopril sodium Tablet, uncoated 10 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 10/12/2024 droperidol Injection, solution 2.5 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 10/12/2024 albendazole Tablet, chewable 200 mg Current Unavailable Manufacturing 10/12/2024 cisatracurium besilate Injection, solution 6.7 mg/mL Current Unavailable Manufacturing 10/12/2024 azithromycin dihydrate Tablet, film coated 628.93 mg Current Unavailable Manufacturing 10/12/2024 norethisterone acetate~estradiol Drug delivery system, transdermal 2.7 mg~.62 mg Current Limited Availability Manufacturing 10/12/2024 adrenaline (epinephrine) acid tartrate Injection, solution 1.82 mg/mL Current Limited Availability Manufacturing 9/12/2024 pantoprazole sodium sesquihydrate Injection, powder for 45.12 mg Discontinued Unavailable Manufacturing 9/12/2024 acetylcysteine Injection, concentrated 2 g Current Limited Availability Transport / Logistic issues / Storage capacity issues 9/12/2024 tobramycin Injection, solution 40 mg/mL Current Limited Availability Unexpected increase in consumer demand 9/12/2024 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 2 mg/mL Resolved Available Transport / Logistic issues / Storage capacity issues 9/12/2024 adrenaline (epinephrine) acid tartrate Injection, solution 1.819 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 9/12/2024 hydromorphone hydrochloride Injection, solution 2 mg Resolved Available Manufacturing 9/12/2024 Fremanezumab Injection, solution 225 mg Anticipated Available Unexpected increase in consumer demand 9/12/2024 sodium amidotrizoate~amidotrizoate meglumine Injection, intravenous infusion 40 mg/mL~260 mg/mL Resolved Available Manufacturing 9/12/2024 clarithromycin Oral Liquid, powder for 50 mg/mL Resolved Available Unexpected increase in consumer demand 9/12/2024 - 2024.12.09
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated bupivacaine hydrochloride Injection, solution 5 mg/mL Current Unavailable Manufacturing 6/12/2024 lidocaine hydrochloride Injection, solution 10 mg/mL Current Unavailable Manufacturing 6/12/2024 finasteride Tablet, film coated 1 mg Resolved Available Unexpected increase in consumer demand 6/12/2024 docetaxel Injection, concentrated 80 mg Current Limited Availability Manufacturing 6/12/2024 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 8 mg Current Unavailable Manufacturing 6/12/2024 clonidine hydrochloride Tablet 100 microgram Current Unavailable Unexpected increase in consumer demand 6/12/2024 adenosine Solution 30 mg Current Limited Availability Manufacturing 6/12/2024 lorazepam Tablet 2.5 mg Anticipated Available Manufacturing 6/12/2024 estradiol hemihydrate Drug delivery system, transdermal 1.54 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 6/12/2024 estradiol hemihydrate Drug delivery system, transdermal .77 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 6/12/2024 estradiol hemihydrate Drug delivery system, transdermal 3.09 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 6/12/2024 estradiol hemihydrate Drug delivery system, transdermal 2.32 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 6/12/2024 olanzapine Injection, powder for 10 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 6/12/2024 amlodipine besilate Tablet, uncoated 6.94 mg Current Limited Availability Manufacturing 5/12/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Discontinued Unavailable Manufacturing 5/12/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Discontinued Unavailable Manufacturing 5/12/2024 rasagiline mesilate Tablet 1.56 mg Resolved Available Manufacturing 5/12/2024 letrozole Tablet, film coated 2.5 mg Resolved Available Manufacturing 5/12/2024 nebivolol hydrochloride Tablet 1.363 mg Current Limited Availability Manufacturing 5/12/2024 nebivolol hydrochloride Tablet 5.45 mg Current Unavailable Manufacturing 5/12/2024 gemfibrozil Tablet, film coated 600 mg Current Limited Availability Manufacturing 5/12/2024 metformin hydrochloride Tablet, film coated 850 mg Current Unavailable Manufacturing 5/12/2024 nizatidine Capsule 150 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 5/12/2024 nizatidine Capsule 300 mg Current Limited Availability Manufacturing 5/12/2024 moclobemide Tablet, film coated 150 mg Current Limited Availability Manufacturing 5/12/2024 testosterone enantate Injection 250 mg/mL Anticipated Available Unexpected increase in consumer demand 4/12/2024 acetylcysteine Injection, concentrated 2 g Current Limited Availability Manufacturing 4/12/2024 sodium fluoride Injection, concentrated 1 mg/mL Current Limited Availability Manufacturing 4/12/2024 fentanyl Drug delivery system, transdermal 2.1 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 4/12/2024 fentanyl Drug delivery system, transdermal 16.8 mg Anticipated Available Manufacturing 4/12/2024 dopamine hydrochloride Injection, concentrated 40 mg/mL Current Limited Availability Manufacturing 4/12/2024 hydrochlorothiazide~telmisartan Tablet, film coated 12.5 mg~80 mg Resolved Available Manufacturing 4/12/2024 acarbose Tablet 100 mg Current Unavailable Manufacturing 4/12/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 4/12/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Manufacturing 4/12/2024 lamotrigine Tablet, chewable 100 mg Anticipated Available Unexpected increase in consumer demand 4/12/2024 lamotrigine Tablet, chewable 200 mg Anticipated Available Unexpected increase in consumer demand 4/12/2024 midazolam Injection, solution 1 mg/mL Resolved Available Manufacturing 4/12/2024 tobramycin Inhalation, conventional 60 mg/mL Resolved Available Manufacturing 4/12/2024 bupivacaine hydrochloride monohydrate Injection, solution 52.7 mg Resolved Available Manufacturing 3/12/2024 topiramate Tablet, film coated 50 mg Anticipated Available Manufacturing 3/12/2024 olanzapine pamoate monohydrate Injection, powder for 931 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 3/12/2024 olanzapine pamoate monohydrate Injection, powder for 690 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 3/12/2024 olanzapine pamoate monohydrate Injection, powder for 483 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 3/12/2024 benzathine benzylpenicillin tetrahydrate Injection, suspension 1200000 USP Unit Current Limited Availability Manufacturing 3/12/2024 azithromycin dihydrate Tablet, film coated 524.1 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 3/12/2024 silver sulfadiazine Cream 10 mg/g Current Unavailable Manufacturing 3/12/2024 silver sulfadiazine Cream 10 mg/g Current Unavailable Manufacturing 3/12/2024 risperidone Tablet, film coated 1 mg Current Unavailable Manufacturing 3/12/2024 carbidopa monohydrate~entacapone~levodopa Tablet, film coated 33.75 mg~200 mg~125 mg Anticipated Available Manufacturing 3/12/2024 midazolam Injection, solution 5 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 3/12/2024 midazolam Injection, solution 5 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 3/12/2024 desvenlafaxine Tablet, modified release 50 mg Anticipated Available Manufacturing 3/12/2024 temozolomide Capsule, hard 20 mg Current Unavailable Manufacturing 3/12/2024 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Manufacturing 3/12/2024 hydromorphone hydrochloride Injection, solution 2 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 3/12/2024 tadalafil Tablet, film coated 10 mg Anticipated Available Manufacturing 3/12/2024 nebivolol hydrochloride Tablet 5.45 mg Anticipated Available Manufacturing 3/12/2024 nizatidine Capsule, hard 150 mg Current Unavailable Manufacturing 3/12/2024 tadalafil Tablet, film coated 5 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 3/12/2024 tenofovir disoproxil fumarate Tablet 300 mg Current Unavailable Manufacturing 3/12/2024 pregabalin Capsule, hard 75 mg Anticipated Available Unexpected increase in consumer demand 3/12/2024 nebivolol hydrochloride Tablet 5.45 mg Current Limited Availability Manufacturing 3/12/2024 nebivolol hydrochloride Tablet 5.45 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 3/12/2024 aciclovir Injection, solution 25 mg/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 3/12/2024 thiotepa Injection, powder for 15 mg Resolved Available Unexpected increase in consumer demand 3/12/2024 lanreotide acetate Injection, solution 66.67 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 3/12/2024 melatonin Capsule, hard 5 mg Current Limited Availability Unexpected increase in consumer demand 3/12/2024 dabigatran etexilate mesilate Capsule 86.475 mg Resolved Available Manufacturing 3/12/2024 aciclovir Injection, solution 25 mg/mL Current Unavailable Manufacturing 3/12/2024 clonidine hydrochloride Tablet, uncoated 150 microgram Resolved Available Manufacturing 3/12/2024 quinapril hydrochloride~hydrochlorothiazide Tablet, film coated 10.832 mg~12.5 mg Current Unavailable Manufacturing 3/12/2024 hydrochlorothiazide~quinapril hydrochloride Tablet, film coated 12.5 mg~21.664 mg Current Unavailable Manufacturing 3/12/2024 esomeprazole sodium Injection, powder for 42.5 mg Resolved Available Manufacturing 3/12/2024 anidulafungin Injection, powder for 100 mg Resolved Available Manufacturing 2/12/2024 pentetic acid Injection, powder for 5 mg Current Emergency Supply Only Manufacturing 2/12/2024 medronic acid Injection, powder for 10 mg Current Limited Availability Manufacturing 2/12/2024 papaverine hydrochloride Injection, solution 12 mg/mL Resolved Available Manufacturing 2/12/2024 tacrolimus monohydrate Capsule, hard 1.022 mg Resolved Available Manufacturing 2/12/2024 levetiracetam Tablet, film coated 250 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 2/12/2024 levetiracetam Tablet, film coated 500 mg Anticipated Available Manufacturing 2/12/2024 acetylcysteine Injection, concentrated 2 g Current Limited Availability Transport / Logistic issues / Storage capacity issues 2/12/2024 diazepam Tablet, uncoated 2 mg Current Limited Availability Manufacturing 2/12/2024 galantamine hydrobromide Capsule, modified release 20.504 mg Anticipated Available Manufacturing 2/12/2024 sumatriptan succinate Tablet, film coated 69.99 mg Resolved Available Unexpected increase in consumer demand 2/12/2024 hydrochlorothiazide~olmesartan medoxomil Tablet, film coated 25 mg~40 mg Resolved Available Manufacturing 2/12/2024 fenofibrate Tablet 48 mg Anticipated Available Manufacturing 2/12/2024 azithromycin dihydrate Tablet, film coated 524 mg Current Unavailable Manufacturing 2/12/2024 acamprosate calcium Tablet, enteric coated 333 mg Anticipated Available Manufacturing 2/12/2024 dasatinib Tablet, film coated 50 mg Resolved Available Manufacturing 2/12/2024 dasatinib Tablet, film coated 100 mg Resolved Available Manufacturing 2/12/2024 dasatinib Tablet, film coated 70 mg Resolved Available Commercial Changes / Commercial viability 2/12/2024 atomoxetine hydrochloride Capsule, hard 114 mg Anticipated Available Manufacturing 2/12/2024 benzathine benzylpenicillin tetrahydrate Injection, suspension 600000 USP Unit Current Unavailable Manufacturing 2/12/2024 lacosamide Tablet, film coated 50 mg Current Limited Availability Manufacturing 2/12/2024 lacosamide Tablet, film coated 150 mg Resolved Available Manufacturing 2/12/2024 levetiracetam Tablet, film coated 1000 mg Current Unavailable Manufacturing 2/12/2024 pregabalin Capsule, hard 150 mg Resolved Available Manufacturing 2/12/2024 fentanyl citrate Injection, solution 157 microgram Current Unavailable Manufacturing 2/12/2024 erythromycin ethyl succinate Oral Liquid, powder for 468 mg Resolved Available Unexpected increase in consumer demand 2/12/2024 clindamycin phosphate Cream 22.8 mg/g Resolved Available Transport / Logistic issues / Storage capacity issues 2/12/2024 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Current Limited Availability Manufacturing 2/12/2024 methylphenidate hydrochloride Capsule, modified release 40 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 2/12/2024 - 2024.12.02
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated sodium fluoride Injection, concentrated 1 mg/mL Anticipated Available Manufacturing 1/12/2024 acarbose Tablet 100 mg Anticipated Available Manufacturing 1/12/2024 rasagiline mesilate Tablet, uncoated 1.56 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 1/12/2024 testosterone enantate Injection 250 mg/mL Anticipated Available Unexpected increase in consumer demand 29/11/2024 bupivacaine hydrochloride Injection, solution 5 mg/mL Anticipated Available Manufacturing 29/11/2024 topiramate Tablet, film coated 200 mg Current Limited Availability Manufacturing 29/11/2024 timolol maleate Eye Drops, solution 6.83 mg/mL Current Limited Availability Commercial Changes / Commercial viability 29/11/2024 levothyroxine sodium Tablet, uncoated .05 mg Resolved Available Manufacturing 29/11/2024 levothyroxine sodium Tablet, uncoated .075 mg Resolved Available Manufacturing 29/11/2024 levothyroxine sodium Tablet, uncoated .1 mg Resolved Available Manufacturing 29/11/2024 levothyroxine sodium Tablet, uncoated .2 mg Resolved Available Manufacturing 29/11/2024 clonazepam Tablet, uncoated 2 mg Resolved Available Manufacturing 29/11/2024 norethisterone~ethinylestradiol Tablet, uncoated 1 mg~36 microgram Current Limited Availability Manufacturing 29/11/2024 metformin hydrochloride Tablet, film coated 500 mg Current Limited Availability Manufacturing 29/11/2024 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Manufacturing 29/11/2024 nizatidine Capsule 300 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 29/11/2024 chlorhexidine gluconate Solution, irrigation 30 mg Current Limited Availability Manufacturing 28/11/2024 methylphenidate hydrochloride Tablet, modified release 27 mg Anticipated Available Manufacturing 28/11/2024 sodium pyrophosphate Injection, powder for 30 mg Current Unavailable Manufacturing 28/11/2024 phenoxymethylpenicillin potassium Tablet, film coated 280 mg Current Limited Availability Manufacturing 28/11/2024 quetiapine fumarate Tablet, film coated 28.78 mg Current Limited Availability Manufacturing 28/11/2024 metoprolol succinate Tablet, modified release 190 mg Current Limited Availability Manufacturing 28/11/2024 esomeprazole magnesium dihydrate Tablet, enteric coated 21.75 mg Resolved Available Transport / Logistic issues / Storage capacity issues 28/11/2024 ezetimibe~atorvastatin calcium trihydrate Tablet, multilayer 10 mg~21.7 mg Current Unavailable Manufacturing 28/11/2024 atorvastatin calcium trihydrate~ezetimibe Tablet, multilayer 43.4 mg~10 mg Current Unavailable Manufacturing 28/11/2024 atorvastatin calcium trihydrate~ezetimibe Tablet, multilayer 86.8 mg~10 mg Current Unavailable Manufacturing 28/11/2024 methylphenidate hydrochloride Capsule, modified release 60 mg Resolved Available Transport / Logistic issues / Storage capacity issues 28/11/2024 betahistine dihydrochloride Tablet, uncoated 16 mg Current Limited Availability Manufacturing 28/11/2024 cinacalcet hydrochloride Tablet 99.191 mg Current Limited Availability Manufacturing 28/11/2024 deferasirox Tablet, film coated 360 mg Current Unavailable Manufacturing 28/11/2024 paracetamol Tablet, modified release 665 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 28/11/2024 melatonin Oral Liquid, solution 1 mg/mL Current Limited Availability Unexpected increase in consumer demand 28/11/2024 lidocaine hydrochloride monohydrate Injection, solution 20 mg/mL Resolved Available Manufacturing 28/11/2024 lidocaine hydrochloride monohydrate Injection, solution 10 mg/mL Resolved Available Manufacturing 28/11/2024 verapamil hydrochloride Tablet, modified release 180 mg Resolved Available Manufacturing 28/11/2024 clonazepam Tablet, uncoated .5 mg Current Unavailable Manufacturing 28/11/2024 clarithromycin Oral Liquid, powder for 50 mg/mL Current Limited Availability Unexpected increase in consumer demand 28/11/2024 methylphenidate hydrochloride Tablet, modified release 18 mg Current Limited Availability Manufacturing 28/11/2024 methylphenidate hydrochloride Tablet, modified release 36 mg Anticipated Available Manufacturing 28/11/2024 methylphenidate hydrochloride Tablet, modified release 54 mg Current Limited Availability Manufacturing 28/11/2024 pravastatin sodium Tablet, uncoated 40 mg Current Unavailable Manufacturing 28/11/2024 norethisterone Tablet, uncoated 350 microgram Current Unavailable Manufacturing 27/11/2024 gabapentin Capsule, hard 300 mg Anticipated Available Manufacturing 27/11/2024 gentamicin Injection, solution 80 mg Current Unavailable Manufacturing 27/11/2024 montelukast sodium Tablet, chewable 5.2 mg Current Unavailable Manufacturing 27/11/2024 hydrochlorothiazide~valsartan Tablet, film coated 25 mg~320 mg Resolved Available Manufacturing 27/11/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Resolved Available Manufacturing 27/11/2024 betahistine dihydrochloride Tablet 24 mg Current Unavailable Unexpected increase in consumer demand 27/11/2024 ezetimibe Tablet 10 mg Current Unavailable Manufacturing 27/11/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 27/11/2024 montelukast sodium Tablet, chewable 5.2 mg Current Unavailable Manufacturing 27/11/2024 trimethoprim Tablet, uncoated 300 mg Resolved Available Manufacturing 27/11/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 109 mg Current Unavailable Manufacturing 27/11/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 54.5 mg Current Unavailable Manufacturing 27/11/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 27.25 mg Current Unavailable Manufacturing 27/11/2024 prazosin hydrochloride Tablet, uncoated 5.476 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 26/11/2024 Somatropin Injection, powder for 12 mg/mL Current Unavailable Transport / Logistic issues / Storage capacity issues 26/11/2024 rosuvastatin calcium Tablet, film coated 10.42 mg Anticipated Available Manufacturing 26/11/2024 tenofovir disoproxil maleate~emtricitabine Tablet, film coated 300 mg~200 mg Current Unavailable Manufacturing 26/11/2024 tenofovir disoproxil fumarate~emtricitabine Tablet, film coated 300 mg~200 mg Anticipated Available Manufacturing 26/11/2024 atorvastatin calcium trihydrate Tablet, film coated 86.76 mg Anticipated Available Manufacturing 26/11/2024 ropinirole hydrochloride Tablet, film coated .285 mg Anticipated Available Manufacturing 26/11/2024 aciclovir Injection, solution 25 mg/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 26/11/2024 aciclovir Injection, solution 25 mg/mL Current Unavailable Manufacturing 26/11/2024 oseltamivir phosphate Capsule, hard 98.524 mg Resolved Available Unexpected increase in consumer demand 26/11/2024 olmesartan medoxomil~amlodipine besilate Tablet, film coated 40 mg~6.94 mg Current Unavailable Unexpected increase in consumer demand 26/11/2024 dasatinib Tablet, film coated 50 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 26/11/2024 heparin sodium Injection, solution 5000 IU/mL Current Unavailable Manufacturing 26/11/2024 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Current Limited Availability Manufacturing 26/11/2024 acetylcysteine Injection, concentrated 2 g Anticipated Available Manufacturing 25/11/2024 fluticasone furoate Spray, suspension 27.5 microgram Resolved Available Unexpected increase in consumer demand 25/11/2024 amoxicillin trihydrate~potassium clavulanate Suspension, powder for 28.7 mg/mL~7.45 mg/mL Resolved Available Manufacturing 25/11/2024 ibuprofen~codeine phosphate hemihydrate Tablet, film coated 200 mg~12.8 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 25/11/2024 tacrolimus monohydrate Capsule, hard 1.022 mg Current Limited Availability Manufacturing 25/11/2024 dexamethasone sodium phosphate Injection, solution 4.37 mg/mL Resolved Available Manufacturing 25/11/2024 levodopa~carbidopa monohydrate~entacapone Tablet, film coated 125 mg~33.75 mg~200 mg Anticipated Available Manufacturing 25/11/2024 voriconazole Injection, powder for 200 mg Current Unavailable Manufacturing 25/11/2024 ezetimibe Tablet, uncoated 10 mg Anticipated Available Manufacturing 25/11/2024 irbesartan~hydrochlorothiazide Tablet, film coated 300 mg~25 mg Current Unavailable Manufacturing 25/11/2024 nebivolol hydrochloride Tablet 10.9 mg Resolved Available Manufacturing 25/11/2024 nebivolol hydrochloride Tablet 1.363 mg Resolved Available Manufacturing 25/11/2024 levetiracetam Tablet, film coated 1000 mg Current Unavailable Manufacturing 25/11/2024 olanzapine Tablet, uncoated 2.5 mg Anticipated Available Manufacturing 25/11/2024 heparin sodium Injection, solution 1000 IU/mL Current Limited Availability Manufacturing 25/11/2024 - 2024.11.25
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated norethisterone Tablet, uncoated 350 microgram Current Unavailable Manufacturing 22/11/2024 isosorbide dinitrate Tablet, uncoated 5 mg Current Limited Availability Manufacturing 22/11/2024 octreotide Injection, solution 50 microgram Current Unavailable Manufacturing 22/11/2024 midazolam Injection, solution 5 mg Current Limited Availability Manufacturing 22/11/2024 levetiracetam Tablet, film coated 250 mg Current Unavailable Manufacturing 22/11/2024 methotrexate Injection, solution 100 mg/mL Current Unavailable Manufacturing 22/11/2024 rosuvastatin calcium Tablet, film coated 10.42 mg Anticipated Available Manufacturing 22/11/2024 metformin hydrochloride Tablet, film coated 500 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 22/11/2024 clonazepam Tablet, uncoated .5 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 22/11/2024 escitalopram oxalate Tablet, film coated 12.74 mg Current Limited Availability Commercial Changes / Commercial viability 22/11/2024 escitalopram oxalate Tablet, film coated 25.47 mg Current Unavailable Manufacturing 22/11/2024 rasagiline mesilate Tablet 1.56 mg Current Limited Availability Manufacturing 22/11/2024 atorvastatin calcium trihydrate~ezetimibe Tablet, film coated 10.341 mg~10 mg Current Unavailable Manufacturing 22/11/2024 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~10.341 mg Current Limited Availability Manufacturing 22/11/2024 dasatinib propylene glycol Tablet, film coated 81.2 mg Current Unavailable Manufacturing 22/11/2024 Follitropin beta Injection, solution 833 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 22/11/2024 Follitropin beta Injection, solution 833 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 22/11/2024 clonazepam Tablet, uncoated .5 mg Current Limited Availability Manufacturing 22/11/2024 fluticasone propionate Inhalation, pressurised 125 microgram/actuation Current Limited Availability Unexpected increase in consumer demand 22/11/2024 heparin sodium Injection, solution 10 IU/mL Current Unavailable Manufacturing 22/11/2024 ezetimibe Tablet 10 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 22/11/2024 oxazepam Tablet, uncoated 15 mg Current Unavailable Manufacturing 21/11/2024 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Manufacturing 21/11/2024 esomeprazole magnesium dihydrate Tablet, enteric coated 21.75 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 21/11/2024 esomeprazole Capsule, enteric 40 mg Current Limited Availability Manufacturing 21/11/2024 cinacalcet hydrochloride Tablet 99.191 mg Current Limited Availability Manufacturing 21/11/2024 lacosamide Tablet, film coated 150 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 21/11/2024 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Resolved Available Manufacturing 21/11/2024 amlodipine besilate~olmesartan medoxomil Tablet, film coated 6.94 mg~20 mg Current Unavailable Manufacturing 21/11/2024 oxazepam Tablet, uncoated 30 mg Current Unavailable Manufacturing 21/11/2024 gemfibrozil Tablet, film coated 600 mg Current Limited Availability Manufacturing 21/11/2024 tobramycin Inhalation, conventional 60 mg/mL Current Unavailable Manufacturing 21/11/2024 clarithromycin Tablet, film coated 250 mg Current Limited Availability Manufacturing 21/11/2024 moclobemide Tablet, film coated 150 mg Current Limited Availability Manufacturing 21/11/2024 fentanyl Drug delivery system, transdermal 16.8 mg Anticipated Available Manufacturing 20/11/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Limited Availability Manufacturing 20/11/2024 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 8 mg Current Limited Availability Manufacturing 20/11/2024 nicotinic acid Tablet, uncoated 250 mg Current Unavailable Manufacturing 20/11/2024 adrenaline (epinephrine) acid tartrate Injection, solution 1.819 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 20/11/2024 tadalafil Tablet, film coated 5 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 20/11/2024 phentermine hydrochloride Tablet, modified release 49.7 mg Resolved Available Manufacturing 20/11/2024 methotrexate Tablet 10 mg Current Unavailable Manufacturing 20/11/2024 oxcarbazepine Tablet, film coated 150 mg Current Unavailable Manufacturing 20/11/2024 balsalazide sodium Capsule 750 mg Anticipated Available Manufacturing 20/11/2024 sevelamer hydrochloride Tablet, film coated 800 mg Anticipated Available Manufacturing 19/11/2024 fluticasone furoate Spray, suspension 27.5 microgram Current Limited Availability Unexpected increase in consumer demand 19/11/2024 methotrexate Injection, solution 100 mg/mL Resolved Available Manufacturing 19/11/2024 doxorubicin hydrochloride Injection, concentrated 2 mg/mL Current Limited Availability Manufacturing 19/11/2024 montelukast sodium Tablet, film coated 10.4 mg Anticipated Available Manufacturing 19/11/2024 telmisartan~hydrochlorothiazide Tablet, film coated 80 mg~12.5 mg Current Unavailable Manufacturing 19/11/2024 quetiapine fumarate Tablet, film coated 28.78 mg Current Limited Availability Manufacturing 19/11/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 19/11/2024 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 2 mg/mL Current Limited Availability Transport / Logistic issues / Storage capacity issues 19/11/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 19/11/2024 clonidine hydrochloride Tablet 100 microgram Current Unavailable Manufacturing 19/11/2024 ezetimibe Tablet 10 mg Resolved Available Unexpected increase in consumer demand 19/11/2024 ezetimibe Tablet 10 mg Current Unavailable Unexpected increase in consumer demand 19/11/2024 tadalafil Tablet, film coated 5 mg Resolved Available Manufacturing 19/11/2024 tadalafil Tablet, film coated 10 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 19/11/2024 rasagiline mesilate Tablet 1.56 mg Current Limited Availability Manufacturing 19/11/2024 lorazepam Tablet 2.5 mg Anticipated Available Manufacturing 19/11/2024 nebivolol hydrochloride Tablet 5.45 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 19/11/2024 sodium chloride Injection, intravenous infusion 900 mg Resolved Available Manufacturing 19/11/2024 estradiol hemihydrate Drug delivery system, transdermal 1.54 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 19/11/2024 estradiol hemihydrate Drug delivery system, transdermal .77 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 19/11/2024 estradiol hemihydrate Drug delivery system, transdermal 3.09 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 19/11/2024 morphine sulfate pentahydrate Capsule, modified release 120 mg Discontinued Unavailable Commercial Changes / Commercial viability 19/11/2024 estradiol hemihydrate Drug delivery system, transdermal 2.32 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 19/11/2024 oxycodone hydrochloride Oral Liquid, solution 1 mg/mL Current Unavailable Unexpected increase in consumer demand 19/11/2024 alprostadil Injection, powder for 40 microgram/mL Current Unavailable Manufacturing 19/11/2024 zolpidem tartrate Tablet, film coated 10 mg Current Unavailable Manufacturing 18/11/2024 ciprofloxacin hydrochloride Tablet, film coated 832.5 mg Resolved Available Manufacturing 18/11/2024 sodium polystyrene sulfonate Powder 999.3 mg/g Resolved Available Manufacturing 18/11/2024 tacrolimus monohydrate Capsule, hard 1.022 mg Current Unavailable Manufacturing 18/11/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Anticipated Available Manufacturing 18/11/2024 carboplatin Injection, solution 450 mg Current Limited Availability Manufacturing 18/11/2024 rizatriptan benzoate Tablet, orally disintegrating 14.53 mg Anticipated Available Manufacturing 18/11/2024 rizatriptan benzoate Wafer 14.53 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 18/11/2024 rabeprazole sodium Tablet, enteric coated 20 mg Anticipated Available Commercial Changes / Commercial viability 18/11/2024 citalopram hydrobromide Tablet, film coated 12.495 mg Anticipated Available Manufacturing 18/11/2024 citalopram hydrobromide Tablet, film coated 49.98 mg Anticipated Available Manufacturing 18/11/2024 betaxolol hydrochloride Eye Drops, solution 5.6 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 18/11/2024 cisplatin Injection, concentrated 1 mg/mL Current Limited Availability Manufacturing 18/11/2024 latanoprost~timolol maleate Eye Drops, solution .05 mg/mL~6.83 mg/mL Anticipated Available Manufacturing 18/11/2024 pregabalin Capsule, hard 150 mg Resolved Available Manufacturing 18/11/2024 mesalazine Tablet, enteric coated 1.6 g Resolved Available Transport / Logistic issues / Storage capacity issues 18/11/2024 sitagliptin hydrochloride monohydrate~metformin hydrochloride Tablet, modified release 113.37 mg~1000 mg Current Limited Availability Manufacturing 18/11/2024 nortriptyline Tablet, film coated 25 mg Resolved Available Manufacturing 18/11/2024 betaxolol hydrochloride Eye Drops, solution 5.6 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 18/11/2024 finasteride Tablet, film coated 1 mg Anticipated Available Unexpected increase in consumer demand 15/11/2024 dutasteride~tamsulosin hydrochloride Capsule, modified release 500 microgram~400 microgram Current Limited Availability Manufacturing 15/11/2024 Somatropin Injection, powder for 12 mg/mL Anticipated Available Transport / Logistic issues / Storage capacity issues 15/11/2024 acetylcysteine Injection, concentrated 2 g Current Unavailable Transport / Logistic issues / Storage capacity issues 15/11/2024 exemestane Tablet, film coated 25 mg Current Unavailable Manufacturing 15/11/2024 metoprolol succinate Tablet, modified release 95 mg Anticipated Available Manufacturing 15/11/2024 metoprolol succinate Tablet, modified release 47.5 mg Anticipated Available Manufacturing 15/11/2024 entecavir Tablet, film coated .5 mg Anticipated Available Manufacturing 15/11/2024 esomeprazole Capsule, enteric 20 mg Anticipated Available Manufacturing 15/11/2024 emtricitabine~tenofovir disoproxil fumarate Tablet, film coated 200 mg~300 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 15/11/2024 indometacin Capsule, hard 25 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 15/11/2024 methylphenidate hydrochloride Tablet, modified release 54 mg Current Limited Availability Manufacturing 15/11/2024 esomeprazole sodium Injection, powder for 42.5 mg Anticipated Available Manufacturing 15/11/2024 prazosin hydrochloride Tablet, uncoated 1.095 mg Anticipated Available Unexpected increase in consumer demand 14/11/2024 sumatriptan succinate Tablet, film coated 140 mg Current Unavailable Manufacturing 14/11/2024 ropivacaine hydrochloride Injection, solution 2 mg/mL Current Unavailable Commercial Changes / Commercial viability 14/11/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 14/11/2024 metoprolol succinate Tablet, modified release 190 mg Anticipated Available Manufacturing 14/11/2024 tenofovir disoproxil maleate Tablet, film coated 300 mg Anticipated Available Manufacturing 14/11/2024 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Resolved Available Manufacturing 14/11/2024 carmustine Injection, powder for 100 mg Resolved Available Manufacturing 14/11/2024 chloramphenicol Eye Drops, solution 5 mg/mL Current Unavailable Manufacturing 14/11/2024 thiotepa Injection, powder for 15 mg Anticipated Available Unexpected increase in consumer demand 14/11/2024 lanreotide acetate Injection, solution 133.33 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 14/11/2024 verapamil hydrochloride Tablet, modified release 180 mg Current Unavailable Manufacturing 14/11/2024 metformin hydrochloride Tablet, film coated 850 mg Current Unavailable Manufacturing 14/11/2024 clonidine hydrochloride Tablet, uncoated 150 microgram Current Unavailable Manufacturing 14/11/2024 amoxicillin sodium Injection, powder for 1060 mg Current Limited Availability Manufacturing 14/11/2024 pravastatin sodium Tablet, uncoated 40 mg Current Unavailable Manufacturing 14/11/2024 HPV Type 16 L1 Protein~HPV Type 18 L1 Protein Injection, suspension 20 microgram~20 microgram Discontinued Unavailable Commercial Changes / Commercial viability 13/11/2024 heparin sodium Injection, solution 5000 IU/mL Current Limited Availability Unexpected increase in consumer demand 13/11/2024 clopidogrel besilate Tablet, film coated 112.1 mg Anticipated Available Manufacturing 13/11/2024 carbamazepine Tablet, modified release 200 mg Current Unavailable Manufacturing 13/11/2024 prazosin hydrochloride Tablet, uncoated 1.1 mg Current Unavailable Manufacturing 13/11/2024 prazosin hydrochloride Tablet, uncoated 2.2 mg Current Unavailable Manufacturing 13/11/2024 galantamine hydrobromide Capsule, modified release 20.504 mg Anticipated Available Manufacturing 12/11/2024 cisatracurium besilate Injection, solution 14.07 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 12/11/2024 ezetimibe Tablet 10 mg Current Unavailable Manufacturing 12/11/2024 atomoxetine hydrochloride Capsule, hard 114 mg Anticipated Available Manufacturing 12/11/2024 prasugrel Tablet, film coated 10 mg Resolved Available Manufacturing 12/11/2024 sitagliptin fumarate Tablet, film coated 32.124 mg Current Limited Availability Manufacturing 12/11/2024 ezetimibe Tablet 10 mg Current Unavailable Manufacturing 12/11/2024 primidone Tablet, uncoated 250 mg Resolved Available Manufacturing 11/11/2024 topiramate Tablet, film coated 100 mg Anticipated Available Manufacturing 11/11/2024 topiramate Tablet, film coated 200 mg Anticipated Available Manufacturing 11/11/2024 tramadol hydrochloride Tablet, modified release 200 mg Anticipated Available Manufacturing 11/11/2024 metoprolol succinate Tablet, modified release 47.5 mg Current Unavailable Manufacturing 11/11/2024 metoprolol succinate Tablet, modified release 190 mg Current Unavailable Manufacturing 11/11/2024 metoprolol succinate Tablet, modified release 95 mg Current Unavailable Manufacturing 11/11/2024 bisoprolol fumarate Tablet 2.5 mg Current Unavailable Manufacturing 11/11/2024 zolmitriptan Tablet, film coated 2.5 mg Current Unavailable Manufacturing 11/11/2024 zolmitriptan Tablet, film coated 2.5 mg Current Unavailable Manufacturing 11/11/2024 fluconazole Capsule, hard 200 mg Resolved Available Manufacturing 11/11/2024 mycophenolate sodium Tablet, enteric coated 384.7 mg Current Unavailable Manufacturing 11/11/2024 alprostadil Injection, powder for 20 microgram/mL Resolved Available Manufacturing 11/11/2024 - 2024.11.11
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated bupivacaine hydrochloride monohydrate Injection, solution 52.7 mg Current Unavailable Manufacturing 8/11/2024 amlodipine besilate Tablet, uncoated 6.94 mg Anticipated Available Manufacturing 8/11/2024 midazolam Injection, solution 5 mg/mL Current Limited Availability Manufacturing 8/11/2024 sodium pyrophosphate Injection, powder for 30 mg Current Emergency Supply Only Manufacturing 8/11/2024 potassium clavulanate~amoxicillin trihydrate Suspension, powder for 7.45 mg/mL~28.7 mg/mL Current Unavailable Manufacturing 8/11/2024 benzathine benzylpenicillin tetrahydrate Injection, suspension 1200000 USP Unit Anticipated Available Manufacturing 8/11/2024 iopromide Injection, solution 498.72 mg/mL Resolved Available Unexpected increase in consumer demand 8/11/2024 hydrocortisone sodium succinate Injection, powder for 334.25 mg Resolved Available Manufacturing 8/11/2024 acetylcysteine Injection, concentrated 2 g Current Unavailable Transport / Logistic issues / Storage capacity issues 8/11/2024 diazepam Tablet, uncoated 2 mg Anticipated Available Manufacturing 8/11/2024 risperidone Tablet, film coated 2 mg Anticipated Available Unexpected increase in consumer demand 8/11/2024 zolmitriptan Tablet, film coated 2.5 mg Current Unavailable Manufacturing 8/11/2024 duloxetine hydrochloride Capsule, enteric 33.66 mg Current Unavailable Unexpected increase in consumer demand 8/11/2024 citalopram hydrobromide Tablet, film coated 49.98 mg Current Unavailable Manufacturing 8/11/2024 meloxicam Capsule, hard 15 mg Resolved Available Manufacturing 8/11/2024 anastrozole Tablet, film coated 1 mg Current Limited Availability Manufacturing 8/11/2024 fluorouracil Injection, solution 50 mg/mL Current Limited Availability Manufacturing 8/11/2024 mesalazine Tablet, enteric coated 250 mg Anticipated Available Manufacturing 8/11/2024 benzathine benzylpenicillin tetrahydrate Injection, suspension 600000 USP Unit Current Unavailable Manufacturing 8/11/2024 nebivolol hydrochloride Tablet 1.363 mg Current Limited Availability Manufacturing 8/11/2024 nebivolol hydrochloride Tablet 5.45 mg Current Limited Availability Manufacturing 8/11/2024 nebivolol hydrochloride Tablet 10.9 mg Resolved Available Manufacturing 8/11/2024 hydrochlorothiazide~amlodipine besilate~olmesartan medoxomil Tablet, film coated 12.5 mg~6.95 mg~40 mg Resolved Available Manufacturing 8/11/2024 tamoxifen citrate Tablet 30.34 mg Current Limited Availability Manufacturing 8/11/2024 lurasidone hydrochloride Tablet, film coated 80 mg Resolved Available Manufacturing 8/11/2024 lurasidone hydrochloride Tablet, film coated 40 mg Resolved Available Manufacturing 8/11/2024 lanreotide acetate Injection, solution 100 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 8/11/2024 lanreotide acetate Injection, solution 66.67 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 8/11/2024 daptomycin Inhalation, powder for 350 mg Current Limited Availability Manufacturing 8/11/2024 morphine sulfate pentahydrate Tablet, film coated 10 mg Discontinued Unavailable Commercial Changes / Commercial viability 8/11/2024 clindamycin phosphate Cream 22.8 mg/g Anticipated Available Transport / Logistic issues / Storage capacity issues 8/11/2024 clonazepam Tablet, uncoated .5 mg Current Limited Availability Manufacturing 8/11/2024 cabergoline Tablet, uncoated 2 mg Current Limited Availability Manufacturing 8/11/2024 baclofen Tablet, uncoated 25 mg Resolved Available Transport / Logistic issues / Storage capacity issues 8/11/2024 adrenaline (epinephrine) acid tartrate Injection, solution 1.82 mg/mL Anticipated Available Manufacturing 7/11/2024 fluconazole Capsule, hard 200 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 7/11/2024 olanzapine Tablet, orally disintegrating 20 mg Anticipated Available Manufacturing 7/11/2024 dutasteride~tamsulosin hydrochloride Capsule, modified release 500 microgram~400 microgram Current Limited Availability Manufacturing 7/11/2024 tacrolimus monohydrate Capsule, hard 1.022 mg Anticipated Available Manufacturing 7/11/2024 bisoprolol fumarate Tablet 10 mg Current Unavailable Manufacturing 7/11/2024 levetiracetam Tablet, film coated 1000 mg Current Unavailable Manufacturing 7/11/2024 escitalopram oxalate Tablet, film coated 12.74 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 7/11/2024 escitalopram oxalate Tablet, film coated 25.47 mg Current Unavailable Manufacturing 7/11/2024 carboplatin Injection, solution 450 mg Anticipated Available Manufacturing 7/11/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 7/11/2024 simvastatin Tablet, film coated 20 mg Current Unavailable Manufacturing 7/11/2024 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 8 mg Current Limited Availability Manufacturing 7/11/2024 hydrochlorothiazide~irbesartan Tablet, film coated 12.5 mg~300 mg Anticipated Available Manufacturing 7/11/2024 cerliponase alfa Injection, solution 30 mg/mL Resolved Available Manufacturing 7/11/2024 dutasteride~tamsulosin hydrochloride Capsule, modified release 500 microgram~400 microgram Resolved Available Transport / Logistic issues / Storage capacity issues 7/11/2024 estradiol Drug delivery system, transdermal .39 mg Current Unavailable Manufacturing 7/11/2024 estradiol Drug delivery system, transdermal 1.56 mg Current Unavailable Manufacturing 7/11/2024 trimethoprim Tablet, uncoated 300 mg Current Limited Availability Manufacturing 7/11/2024 flecainide acetate Tablet 50 mg Current Unavailable Manufacturing 7/11/2024 cefaclor monohydrate Oral Liquid, powder for 52.45 mg/mL Current Unavailable Unexpected increase in consumer demand 7/11/2024 potassium clavulanate~amoxicillin trihydrate Tablet, film coated 149 mg~574 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 7/11/2024 tirzepatide Injection, solution 7.5 mg Current Unavailable Commercial Changes / Commercial viability 7/11/2024 tirzepatide Injection, solution 12.5 mg Current Unavailable Commercial Changes / Commercial viability 7/11/2024 tirzepatide Injection, solution 10 mg Current Unavailable Commercial Changes / Commercial viability 7/11/2024 tirzepatide Injection, solution 2.5 mg Current Unavailable Commercial Changes / Commercial viability 7/11/2024 nizatidine Capsule 300 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 7/11/2024 clarithromycin Tablet, film coated 250 mg Current Limited Availability Unexpected increase in consumer demand 7/11/2024 fluticasone furoate Spray, suspension 27.5 microgram Anticipated Available Unexpected increase in consumer demand 6/11/2024 silver sulfadiazine Cream 10 mg/g Current Unavailable Manufacturing 6/11/2024 mycophenolate mofetil Tablet, film coated 500 mg Current Unavailable Manufacturing 6/11/2024 sildenafil citrate Tablet, film coated 28.1 mg Current Limited Availability Manufacturing 6/11/2024 mycophenolate mofetil Tablet, film coated 500 mg Resolved Available Manufacturing 6/11/2024 esomeprazole Capsule, enteric 40 mg Current Limited Availability Manufacturing 6/11/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 6/11/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 6/11/2024 atomoxetine hydrochloride Capsule, hard 91.2 mg Resolved Available Manufacturing 6/11/2024 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Current Limited Availability Manufacturing 6/11/2024 norethisterone acetate~estradiol~estradiol Drug delivery system, transdermal 2.7 mg~.78 mg~.62 mg Current Limited Availability Manufacturing 6/11/2024 norethisterone acetate~estradiol~estradiol Drug delivery system, transdermal 4.8 mg~.512 mg~.78 mg Current Limited Availability Manufacturing 6/11/2024 estradiol Drug delivery system, transdermal .585 mg Current Unavailable Manufacturing 6/11/2024 estradiol Drug delivery system, transdermal .78 mg Current Unavailable Manufacturing 6/11/2024 estradiol Drug delivery system, transdermal 1.17 mg Current Unavailable Manufacturing 6/11/2024 chloramphenicol Eye Drops, solution 5 mg/mL Current Unavailable Manufacturing 6/11/2024 melatonin Capsule, hard 5 mg Current Limited Availability Unexpected increase in consumer demand 6/11/2024 estradiol~norethisterone acetate Drug delivery system, transdermal .62 mg~2.7 mg Current Unavailable Manufacturing 6/11/2024 norethisterone acetate~estradiol Drug delivery system, transdermal 4.8 mg~.512 mg Current Limited Availability Manufacturing 6/11/2024 risperidone Tablet, film coated 4 mg Current Unavailable Manufacturing 5/11/2024 oxytocin Injection, solution 10 IU Current Unavailable Manufacturing 5/11/2024 progesterone Pessary, compressed 100 mg Current Unavailable Manufacturing 5/11/2024 citalopram hydrobromide Tablet, film coated 12.495 mg Anticipated Available Manufacturing 5/11/2024 citalopram hydrobromide Tablet, film coated 49.98 mg Anticipated Available Manufacturing 5/11/2024 azithromycin dihydrate Tablet, film coated 524 mg Current Unavailable Manufacturing 5/11/2024 hydrochlorothiazide~irbesartan Tablet, film coated 25 mg~300 mg Anticipated Available Manufacturing 5/11/2024 tenofovir disoproxil fumarate~emtricitabine Tablet, film coated 300 mg~200 mg Resolved Available Manufacturing 5/11/2024 tadalafil Tablet, film coated 10 mg Current Unavailable Manufacturing 5/11/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 5/11/2024 timolol maleate Eye Drops, solution 6.83 mg/mL Anticipated Available Commercial Changes / Commercial viability 5/11/2024 levothyroxine sodium Tablet 50 microgram Current Unavailable Manufacturing 5/11/2024 melatonin Oral Liquid, solution 1 mg/mL Current Limited Availability Unexpected increase in consumer demand 5/11/2024 timolol maleate Eye Drops, solution 6.84 mg/mL Current Unavailable Manufacturing 5/11/2024 gefitinib Tablet, film coated 250 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 5/11/2024 ciprofloxacin hydrochloride Tablet, film coated 832.5 mg Current Unavailable Manufacturing 4/11/2024 morphine hydrochloride trihydrate Oral Liquid, solution 2 mg/mL Resolved Available Commercial Changes / Commercial viability 4/11/2024 morphine hydrochloride trihydrate Oral Liquid, solution 10 mg/mL Current Unavailable Commercial Changes / Commercial viability 4/11/2024 metformin hydrochloride Tablet, film coated 1000 mg Current Limited Availability Manufacturing 4/11/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 4/11/2024 irbesartan Tablet, film coated 300 mg Current Unavailable Manufacturing 4/11/2024 pregabalin Capsule, hard 150 mg Anticipated Available Manufacturing 4/11/2024 quinagolide hydrochloride Tablet, uncoated .0819 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 4/11/2024 verapamil hydrochloride Tablet, modified release 180 mg Current Limited Availability Manufacturing 4/11/2024 morphine sulfate pentahydrate Capsule, modified release 90 mg Discontinued Unavailable Commercial Changes / Commercial viability 4/11/2024 clonidine hydrochloride Tablet, uncoated 150 microgram Current Limited Availability Manufacturing 4/11/2024 - 2024.11.04
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated primidone Tablet, uncoated 250 mg Current Limited Availability Manufacturing 1/11/2024 gentamicin Injection, solution 80 mg Current Limited Availability Manufacturing 1/11/2024 sodium pyrophosphate Injection, powder for 30 mg Current Emergency Supply Only Manufacturing 1/11/2024 Pancreatic extract Capsule, enteric 150 mg Resolved Available Unexpected increase in consumer demand 1/11/2024 silver sulfadiazine Cream 10 mg/g Current Unavailable Manufacturing 1/11/2024 hydrocortisone sodium succinate Injection, powder for 134 mg Resolved Available Manufacturing 1/11/2024 hydrocortisone sodium succinate Injection, powder for 334.25 mg Current Limited Availability Manufacturing 1/11/2024 levetiracetam Tablet, film coated 500 mg Anticipated Available Manufacturing 1/11/2024 ciprofloxacin hydrochloride Tablet, film coated 277.5 mg Current Unavailable Manufacturing 1/11/2024 ciprofloxacin hydrochloride Tablet, film coated 555 mg Current Limited Availability Manufacturing 1/11/2024 ciprofloxacin hydrochloride Tablet, film coated 832.5 mg Current Unavailable Manufacturing 1/11/2024 candesartan cilexetil Tablet, uncoated 4 mg Anticipated Available Manufacturing 1/11/2024 rizatriptan benzoate Tablet, orally disintegrating 14.53 mg Resolved Available Manufacturing 1/11/2024 tranexamic acid Injection, solution 1000 mg Current Limited Availability Commercial Changes / Commercial viability 1/11/2024 acarbose Tablet 100 mg Current Limited Availability Manufacturing 1/11/2024 acarbose Tablet 50 mg Current Unavailable Manufacturing 1/11/2024 acarbose Tablet 50 mg Current Unavailable Manufacturing 1/11/2024 cisatracurium besilate Injection, solution 14.07 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 1/11/2024 Follitropin alfa Injection, solution 75 IU Current Unavailable Manufacturing 1/11/2024 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 8 mg Current Limited Availability Manufacturing 1/11/2024 anastrozole Tablet, film coated 1 mg Anticipated Available Manufacturing 1/11/2024 cisplatin Injection, concentrated 1 mg/mL Current Unavailable Unexpected increase in consumer demand 1/11/2024 lacosamide Tablet, film coated 100 mg Resolved Available Commercial Changes / Commercial viability 1/11/2024 lacosamide Tablet, film coated 50 mg Resolved Available Manufacturing 1/11/2024 pregabalin Capsule, hard 150 mg Anticipated Available Manufacturing 1/11/2024 pregabalin Capsule, hard 25 mg Anticipated Available Manufacturing 1/11/2024 pregabalin Capsule, hard 75 mg Anticipated Available Manufacturing 1/11/2024 montelukast sodium Tablet, film coated 10.4 mg Resolved Available Manufacturing 1/11/2024 norethisterone acetate~estradiol~estradiol Drug delivery system, transdermal 4.8 mg~.512 mg~.78 mg Current Limited Availability Manufacturing 1/11/2024 estradiol Drug delivery system, transdermal .585 mg Current Unavailable Manufacturing 1/11/2024 estradiol Drug delivery system, transdermal 1.56 mg Current Unavailable Manufacturing 1/11/2024 mycophenolate sodium Tablet, enteric coated 384.7 mg Anticipated Available Manufacturing 1/11/2024 phentermine hydrochloride Tablet, modified release 49.7 mg Current Limited Availability Manufacturing 1/11/2024 flecainide acetate Tablet 50 mg Current Unavailable Manufacturing 1/11/2024 carmustine Injection, powder for 100 mg Current Limited Availability Manufacturing 1/11/2024 cefaclor monohydrate Oral Liquid, powder for 52.45 mg/mL Current Unavailable Unexpected increase in consumer demand 1/11/2024 cisplatin Injection, solution 1 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 1/11/2024 dorzolamide hydrochloride Eye Drops, solution 22.26 mg/mL Current Unavailable Manufacturing 1/11/2024 estradiol hemihydrate Drug delivery system, transdermal 2.32 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 1/11/2024 oxycodone hydrochloride Oral Liquid, solution 1 mg/mL Current Limited Availability Unexpected increase in consumer demand 1/11/2024 pravastatin sodium Tablet, uncoated 40 mg Current Unavailable Manufacturing 1/11/2024 terbinafine hydrochloride Tablet, uncoated 281.3 mg Anticipated Available Manufacturing 31/10/2024 metformin hydrochloride Tablet, film coated 500 mg Current Unavailable Manufacturing 31/10/2024 gabapentin Tablet, film coated 600 mg Anticipated Available Manufacturing 31/10/2024 doxorubicin hydrochloride Injection, concentrated 2 mg/mL Anticipated Available Manufacturing 31/10/2024 montelukast sodium Tablet, chewable 4.16 mg Anticipated Available Manufacturing 31/10/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Current Limited Availability Manufacturing 31/10/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Current Unavailable Manufacturing 31/10/2024 rizatriptan benzoate Wafer 14.53 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 31/10/2024 meloxicam Capsule, hard 15 mg Current Unavailable Manufacturing 31/10/2024 azacitidine Injection, powder for 100 mg Resolved Available Manufacturing 31/10/2024 rasagiline mesilate Tablet 1.56 mg Current Limited Availability Manufacturing 31/10/2024 bortezomib Injection, solution 3.5 mg Resolved Available Manufacturing 31/10/2024 sitagliptin hydrochloride monohydrate~metformin hydrochloride Tablet, modified release 56.685 mg~1000 mg Current Unavailable Manufacturing 31/10/2024 thiotepa Injection, powder for 15 mg Current Unavailable Commercial Changes / Commercial viability 31/10/2024 clindamycin phosphate Cream 22.8 mg/g Anticipated Available Transport / Logistic issues / Storage capacity issues 31/10/2024 tobramycin Inhalation, conventional 60 mg/mL Current Unavailable Manufacturing 31/10/2024 clarithromycin Tablet, film coated 250 mg Current Limited Availability Manufacturing 31/10/2024 methylphenidate hydrochloride Tablet, modified release 18 mg Current Limited Availability Manufacturing 31/10/2024 morphine sulfate pentahydrate Tablet, modified release 60 mg Current Unavailable Manufacturing 30/10/2024 potassium clavulanate~amoxicillin trihydrate Suspension, powder for 7.45 mg/mL~28.7 mg/mL Current Unavailable Manufacturing 30/10/2024 metoprolol succinate Tablet, modified release 190 mg Current Unavailable Manufacturing 30/10/2024 galantamine hydrobromide Capsule, modified release 30.756 mg Current Limited Availability Manufacturing 30/10/2024 azithromycin dihydrate Tablet, film coated 524.05 mg Current Limited Availability Manufacturing 30/10/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 30/10/2024 cefepime hydrochloride monohydrate Injection, powder for 2378.5 mg Discontinued Unavailable Manufacturing 30/10/2024 cefepime hydrochloride monohydrate Injection, powder for 1189.2 mg Discontinued Unavailable Manufacturing 30/10/2024 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Manufacturing 30/10/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 30/10/2024 tadalafil Tablet, film coated 10 mg Anticipated Available Manufacturing 30/10/2024 nebivolol hydrochloride Tablet 5.45 mg Current Limited Availability Manufacturing 30/10/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 30/10/2024 dasatinib Tablet, film coated 50 mg Current Unavailable Manufacturing 30/10/2024 dasatinib Tablet, film coated 100 mg Current Unavailable Manufacturing 30/10/2024 dasatinib Tablet, film coated 70 mg Current Unavailable Commercial Changes / Commercial viability 30/10/2024 atomoxetine hydrochloride Capsule, hard 45.5 mg Resolved Available Manufacturing 30/10/2024 gefitinib Tablet, film coated 250 mg Current Unavailable Manufacturing 30/10/2024 tamsulosin hydrochloride~dutasteride Capsule, modified release 400 microgram~500 microgram Current Limited Availability Transport / Logistic issues / Storage capacity issues 30/10/2024 olanzapine Tablet, uncoated 2.5 mg Anticipated Available Manufacturing 30/10/2024 dasatinib propylene glycol Tablet, film coated 58 mg Current Unavailable Manufacturing 30/10/2024 dasatinib propylene glycol Tablet, film coated 23.2 mg Discontinued Unavailable Manufacturing 30/10/2024 carbachol Injection, solution 100 microgram/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 30/10/2024 octreotide Injection, solution 50 microgram/mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 30/10/2024 clarithromycin Oral Liquid, powder for 50 mg/mL Current Limited Availability Unexpected increase in consumer demand 30/10/2024 Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain) Injection, powder for 200000000 CFU Current Limited Availability Unexpected increase in consumer demand 30/10/2024 clindamycin hydrochloride Solution 10 mg/mL Resolved Available Manufacturing 30/10/2024 prazosin hydrochloride Tablet, uncoated 1.1 mg Current Unavailable Manufacturing 30/10/2024 prazosin hydrochloride Tablet, uncoated 2.2 mg Current Unavailable Manufacturing 30/10/2024 prazosin hydrochloride Tablet, uncoated 5.5 mg Current Unavailable Manufacturing 30/10/2024 morphine sulfate pentahydrate Tablet, modified release 10 mg Current Unavailable Manufacturing 29/10/2024 morphine sulfate pentahydrate Tablet, modified release 30 mg Current Unavailable Manufacturing 29/10/2024 levetiracetam Tablet, film coated 250 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 29/10/2024 metoprolol succinate Tablet, modified release 95 mg Current Unavailable Manufacturing 29/10/2024 zolmitriptan Tablet, film coated 2.5 mg Anticipated Available Manufacturing 29/10/2024 Digoxinspecific antibody fragment F(ab) (Ovine) Injection, powder for 40 mg Resolved Available Manufacturing 29/10/2024 metformin hydrochloride Tablet, modified release 1000 mg Resolved Available Manufacturing 29/10/2024 pemetrexed disodium Injection, powder for 1102.9 mg Resolved Available Manufacturing 29/10/2024 ezetimibe Tablet, uncoated 10 mg Resolved Available Manufacturing 29/10/2024 fluticasone propionate Inhalation, pressurised 125 microgram/actuation Resolved Available Manufacturing 29/10/2024 tenofovir disoproxil fumarate~emtricitabine Tablet, film coated 300 mg~200 mg Current Limited Availability Manufacturing 29/10/2024 metformin hydrochloride Tablet, film coated 500 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 29/10/2024 tadalafil Tablet, film coated 5 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 29/10/2024 tadalafil Tablet, film coated 20 mg Resolved Available Unexpected increase in consumer demand 29/10/2024 olmesartan medoxomil~amlodipine besilate Tablet, film coated 40 mg~6.935 mg Resolved Available Manufacturing 29/10/2024 prasugrel Tablet, film coated 10 mg Current Limited Availability Manufacturing 29/10/2024 indometacin Capsule, hard 25 mg Resolved Available Manufacturing 29/10/2024 melatonin Capsule, hard 5 mg Anticipated Available Unexpected increase in consumer demand 29/10/2024 melatonin Oral Liquid, solution 1 mg/mL Anticipated Available Unexpected increase in consumer demand 29/10/2024 iopromide Injection, solution 498.72 mg/mL Resolved Available Unexpected increase in consumer demand 29/10/2024 diclofenac sodium Suppository, moulded 50 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 29/10/2024 clarithromycin Tablet, film coated 250 mg Resolved Available Manufacturing 28/10/2024 morphine sulfate pentahydrate Tablet, modified release 100 mg Current Unavailable Manufacturing 28/10/2024 sodium polystyrene sulfonate Powder 999.3 mg/g Anticipated Available Manufacturing 28/10/2024 acetylcysteine Injection, concentrated 2 g Current Limited Availability Transport / Logistic issues / Storage capacity issues 28/10/2024 Hepatitis a virus antigen Injection, suspension 320 AgU/mL Resolved Available Manufacturing 28/10/2024 metoprolol succinate Tablet, modified release 190 mg Anticipated Available Manufacturing 28/10/2024 midazolam Injection, solution 1 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 28/10/2024 ziprasidone hydrochloride Capsule, hard 65.16 mg Resolved Available Transport / Logistic issues / Storage capacity issues 28/10/2024 chromium(51Cr) edetate Injection, solution 8 MBq/mL Resolved Available Manufacturing 28/10/2024 esomeprazole Capsule, enteric 40 mg Anticipated Available Manufacturing 28/10/2024 nebivolol hydrochloride Tablet 10.9 mg Resolved Available Manufacturing 28/10/2024 lanreotide acetate Injection, solution 133.33 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 28/10/2024 oxycodone hydrochloride Capsule, hard 10 mg Resolved Available Commercial Changes / Commercial viability 28/10/2024 morphine sulfate pentahydrate Capsule, modified release 60 mg Discontinued Unavailable Commercial Changes / Commercial viability 28/10/2024 pamidronate disodium Injection, concentrated 3 mg Resolved Available Manufacturing 28/10/2024 pamidronate disodium Injection, concentrated 6 mg Resolved Available Manufacturing 28/10/2024 - 2024.10.29
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated gabapentin Capsule, hard 300 mg Current Limited Availability Manufacturing 25/10/2024 sumatriptan succinate Tablet, film coated 140 mg Current Limited Availability Manufacturing 25/10/2024 azithromycin dihydrate Tablet, film coated 524.1 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 25/10/2024 dutasteride~tamsulosin hydrochloride Capsule, modified release 500 microgram~400 microgram Current Limited Availability Manufacturing 25/10/2024 valsartan~hydrochlorothiazide Tablet, film coated 320 mg~25 mg Current Limited Availability Manufacturing 25/10/2024 esomeprazole magnesium dihydrate Tablet, enteric coated 21.75 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 25/10/2024 clonidine hydrochloride Tablet 100 microgram Anticipated Available Manufacturing 25/10/2024 fluorouracil Injection, solution 50 mg/mL Resolved Available Manufacturing 25/10/2024 verapamil hydrochloride Tablet, modified release 180 mg Current Limited Availability Manufacturing 25/10/2024 estradiol hemihydrate Drug delivery system, transdermal 1.54 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 25/10/2024 estradiol hemihydrate Drug delivery system, transdermal .77 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 25/10/2024 oxycodone hydrochloride Capsule, hard 5 mg Resolved Available Manufacturing 25/10/2024 nizatidine Capsule 300 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 25/10/2024 flecainide acetate Injection, solution 10 mg/mL Anticipated Available Manufacturing 24/10/2024 topiramate Tablet, film coated 200 mg Anticipated Available Manufacturing 24/10/2024 gliclazide Tablet, modified release 30 mg Resolved Available Manufacturing 24/10/2024 donepezil hydrochloride Tablet, film coated 5 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 24/10/2024 bisoprolol fumarate Tablet 5 mg Current Unavailable Manufacturing 24/10/2024 bicalutamide Tablet, film coated 50 mg Anticipated Available Manufacturing 24/10/2024 azithromycin dihydrate Tablet, film coated 524.05 mg Current Limited Availability Manufacturing 24/10/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Limited Availability Manufacturing 24/10/2024 quetiapine fumarate Tablet, film coated 28.78 mg Anticipated Available Manufacturing 24/10/2024 rizatriptan benzoate Tablet, orally disintegrating 14.53 mg Resolved Available Transport / Logistic issues / Storage capacity issues 24/10/2024 simvastatin Tablet, film coated 40 mg Current Unavailable Manufacturing 24/10/2024 citalopram hydrobromide Tablet, film coated 49.98 mg Current Unavailable Manufacturing 24/10/2024 citalopram hydrobromide Tablet, film coated 49.98 mg Anticipated Available Manufacturing 24/10/2024 mitomycin Injection, powder for 20 mg Resolved Available Manufacturing 24/10/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 24/10/2024 emtricitabine~tenofovir disoproxil maleate Tablet, film coated 200 mg~300 mg Current Unavailable Manufacturing 24/10/2024 prochlorperazine maleate Tablet, uncoated 5 mg Current Unavailable Commercial Changes / Commercial viability 24/10/2024 nebivolol hydrochloride Tablet 1.363 mg Current Unavailable Manufacturing 24/10/2024 betahistine dihydrochloride Tablet, uncoated 16 mg Current Limited Availability Manufacturing 24/10/2024 cinacalcet hydrochloride Tablet 99.191 mg Current Limited Availability Manufacturing 24/10/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 24/10/2024 azacitidine Injection, powder for 100 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 24/10/2024 estradiol Drug delivery system, transdermal 1.56 mg Current Limited Availability Manufacturing 24/10/2024 flecainide acetate Tablet 50 mg Current Unavailable Manufacturing 24/10/2024 bortezomib Injection, solution 3.5 mg Current Unavailable Manufacturing 24/10/2024 paracetamol Tablet, modified release 665 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 24/10/2024 norethisterone acetate~estradiol Drug delivery system, transdermal 4.8 mg~.512 mg Current Limited Availability Manufacturing 24/10/2024 metformin hydrochloride Tablet, film coated 850 mg Current Unavailable Manufacturing 24/10/2024 pravastatin sodium Tablet, uncoated 40 mg Current Limited Availability Manufacturing 24/10/2024 medronic acid Injection, powder for 10 mg Current Limited Availability Manufacturing 23/10/2024 donepezil hydrochloride Tablet, film coated 10 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 23/10/2024 levetiracetam Tablet, film coated 250 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 23/10/2024 bisoprolol fumarate Tablet 2.5 mg Current Unavailable Manufacturing 23/10/2024 bisoprolol fumarate Tablet 10 mg Anticipated Available Manufacturing 23/10/2024 irbesartan Tablet, film coated 300 mg Resolved Available Manufacturing 23/10/2024 methotrexate Injection, solution 100 mg/mL Current Unavailable Manufacturing 23/10/2024 epirubicin hydrochloride Injection, concentrated 200 mg Current Unavailable Manufacturing 23/10/2024 betahistine dihydrochloride Tablet 24 mg Current Limited Availability Unexpected increase in consumer demand 23/10/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Manufacturing 23/10/2024 tenofovir disoproxil fumarate~emtricitabine Tablet, film coated 300 mg~200 mg Current Unavailable Manufacturing 23/10/2024 tadalafil Tablet, film coated 10 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 23/10/2024 lacosamide Tablet, film coated 50 mg Anticipated Available Manufacturing 23/10/2024 lidocaine hydrochloride Injection, solution 400 mg Current Unavailable Manufacturing 23/10/2024 amlodipine besilate~olmesartan medoxomil~hydrochlorothiazide Tablet, film coated 6.95 mg~40 mg~25 mg Current Unavailable Manufacturing 23/10/2024 amoxicillin trihydrate Oral Liquid, powder for 114.82 mg/mL Resolved Available Manufacturing 23/10/2024 cytarabine Injection, solution 100 mg Current Limited Availability Unexpected increase in consumer demand 22/10/2024 papaverine hydrochloride Injection, solution 12 mg/mL Current Limited Availability Manufacturing 22/10/2024 clonidine hydrochloride Tablet, uncoated 100 microgram Resolved Available Manufacturing 22/10/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~5.198 mg Resolved Available Manufacturing 22/10/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~20.791 mg Current Limited Availability Manufacturing 22/10/2024 levetiracetam Injection, concentrated 500 mg Resolved Available Manufacturing 22/10/2024 pemetrexed disodium Injection, powder for 1102.9 mg Current Unavailable Manufacturing 22/10/2024 meloxicam Capsule, hard 15 mg Anticipated Available Manufacturing 22/10/2024 cisplatin Injection, concentrated 1 mg/mL Current Unavailable Unexpected increase in consumer demand 22/10/2024 rasagiline mesilate Tablet 1.56 mg Current Limited Availability Manufacturing 22/10/2024 celecoxib Capsule, hard 100 mg Resolved Available Manufacturing 22/10/2024 solifenacin succinate Tablet, film coated 5 mg Current Unavailable Manufacturing 22/10/2024 solifenacin succinate Tablet, film coated 10 mg Current Unavailable Manufacturing 22/10/2024 lacosamide Tablet, film coated 100 mg Resolved Available Manufacturing 22/10/2024 modafinil Tablet, uncoated 100 mg Resolved Available Manufacturing 22/10/2024 quinagolide hydrochloride Tablet, uncoated .0819 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 22/10/2024 clarithromycin Oral Liquid, powder for 50 mg/mL Current Limited Availability Unexpected increase in consumer demand 22/10/2024 norethisterone~ethinylestradiol Tablet, uncoated 1 mg~36 microgram Current Limited Availability Manufacturing 22/10/2024 clonidine hydrochloride Tablet, uncoated 150 microgram Resolved Available Manufacturing 22/10/2024 methylphenidate hydrochloride Tablet, modified release 54 mg Current Limited Availability Manufacturing 22/10/2024 adrenaline (epinephrine) acid tartrate Injection, solution 1.82 mg/mL Anticipated Available Manufacturing 21/10/2024 topiramate Tablet, film coated 25 mg Anticipated Available Manufacturing 21/10/2024 pentetic acid Injection, powder for 5 mg Current Limited Availability Manufacturing 21/10/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~10.396 mg Current Limited Availability Manufacturing 21/10/2024 rosuvastatin calcium~ezetimibe Tablet~Tablet, film coated 20.791 mg~10 mg Current Limited Availability Manufacturing 21/10/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~5.198 mg Current Limited Availability Manufacturing 21/10/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~10.396 mg Resolved Available Manufacturing 21/10/2024 paclitaxel Injection, concentrated 300 mg Resolved Available Manufacturing 21/10/2024 milrinone Injection, concentrated 10 mg Resolved Available Manufacturing 21/10/2024 cefepime hydrochloride monohydrate Injection, powder for 1189.2 mg Current Limited Availability Manufacturing 21/10/2024 temozolomide Capsule, hard 20 mg Anticipated Available Manufacturing 21/10/2024 benzatropine mesilate Injection 1 mg/mL Anticipated Available Manufacturing 21/10/2024 hydromorphone hydrochloride Injection, solution 2 mg Current Limited Availability Manufacturing 21/10/2024 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Anticipated Available Manufacturing 21/10/2024 lenalidomide Capsule, hard 5 mg Resolved Available Unexpected increase in consumer demand 21/10/2024 levothyroxine sodium Tablet 50 microgram Current Unavailable Manufacturing 21/10/2024 clindamycin hydrochloride Solution 10 mg/mL Current Unavailable Manufacturing 21/10/2024 sodium pertechnetate(99mTc) Injection, solution 20 GBq Resolved Available Manufacturing 21/10/2024 balsalazide sodium Capsule 750 mg Resolved Available Commercial Changes / Commercial viability 21/10/2024 - 2024.10.23
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated sumatriptan succinate Tablet, film coated 140 mg Current Limited Availability Manufacturing 18/10/2024 topiramate Tablet, film coated 50 mg Anticipated Available Manufacturing 18/10/2024 topiramate Tablet, film coated 100 mg Anticipated Available Manufacturing 18/10/2024 heparin sodium Injection, solution 5000 IU/mL Anticipated Available Unexpected increase in consumer demand 18/10/2024 tamsulosin hydrochloride~dutasteride Capsule, modified release 400 microgram~500 microgram Current Limited Availability Manufacturing 18/10/2024 metformin hydrochloride Tablet, modified release 1000 mg Current Limited Availability Manufacturing 18/10/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 18/10/2024 oxycodone hydrochloride Capsule, hard 10 mg Current Unavailable Commercial Changes / Commercial viability 18/10/2024 fenofibrate Tablet 48 mg Resolved Available Manufacturing 18/10/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 18/10/2024 latanoprost Eye Drops, solution .05 mg/mL Resolved Available Transport / Logistic issues / Storage capacity issues 18/10/2024 lacosamide Tablet, film coated 150 mg Current Unavailable Manufacturing 18/10/2024 pregabalin Capsule, hard 75 mg Resolved Available Manufacturing 18/10/2024 pregabalin Capsule, hard 75 mg Resolved Available Manufacturing 18/10/2024 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Current Limited Availability Manufacturing 18/10/2024 trimethoprim Tablet, uncoated 300 mg Current Limited Availability Manufacturing 18/10/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 18/10/2024 indometacin Capsule, hard 25 mg Current Unavailable Manufacturing 18/10/2024 octreotide Injection, solution 50 microgram/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 18/10/2024 clonazepam Tablet, uncoated .5 mg Current Limited Availability Manufacturing 18/10/2024 clonazepam Tablet, uncoated 2 mg Current Limited Availability Manufacturing 18/10/2024 estradiol hemihydrate Drug delivery system, transdermal 1.54 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 18/10/2024 tobramycin Inhalation, conventional 60 mg/mL Current Unavailable Manufacturing 18/10/2024 topiramate Tablet, film coated 200 mg Anticipated Available Manufacturing 17/10/2024 adrenaline (epinephrine) Injection, solution 1 mg Resolved Available Manufacturing 17/10/2024 mitomycin Injection, powder for 20 mg Current Unavailable Manufacturing 17/10/2024 azacitidine Injection, powder for 100 mg Current Unavailable Manufacturing 17/10/2024 irbesartan Tablet, film coated 150 mg Resolved Available Manufacturing 17/10/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Manufacturing 17/10/2024 lisdexamfetamine dimesilate Capsule, hard 60 mg Resolved Available Unexpected increase in consumer demand 17/10/2024 letrozole Tablet, film coated 2.5 mg Current Limited Availability Manufacturing 17/10/2024 nebivolol hydrochloride Tablet 5.45 mg Current Limited Availability Manufacturing 17/10/2024 daptomycin Injection, powder for 500 mg Current Unavailable Commercial Changes / Commercial viability 17/10/2024 tamoxifen citrate Tablet 30.34 mg Current Limited Availability Manufacturing 17/10/2024 olanzapine pamoate monohydrate Injection, powder for 931 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 16/10/2024 risperidone Tablet, film coated 4 mg Anticipated Available Manufacturing 16/10/2024 rocuronium bromide Injection, solution 50 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 16/10/2024 adrenaline (epinephrine) Injection, solution 1 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 16/10/2024 atorvastatin calcium trihydrate~ezetimibe Tablet, multilayer 10.9 mg~10 mg Resolved Available Manufacturing 16/10/2024 entecavir Tablet, film coated 1 mg Resolved Available Manufacturing 16/10/2024 hydrochlorothiazide~irbesartan Tablet, film coated 25 mg~300 mg Anticipated Available Manufacturing 16/10/2024 tadalafil Tablet, film coated 10 mg Anticipated Available Manufacturing 16/10/2024 tadalafil Tablet, film coated 5 mg Resolved Available Manufacturing 16/10/2024 cisplatin Injection, concentrated 1 mg/mL Anticipated Available Manufacturing 16/10/2024 linezolid Tablet, film coated 600 mg Resolved Available Unexpected increase in consumer demand 16/10/2024 latanoprost~timolol maleate Eye Drops, solution .05 mg/mL~6.83 mg/mL Anticipated Available Manufacturing 16/10/2024 dutasteride~tamsulosin hydrochloride Capsule, modified release 500 microgram~400 microgram Anticipated Available Transport / Logistic issues / Storage capacity issues 16/10/2024 bendamustine hydrochloride monohydrate Injection, powder for 100 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 16/10/2024 amlodipine besilate~olmesartan medoxomil Tablet, film coated 6.94 mg~40 mg Current Unavailable Unexpected increase in consumer demand 16/10/2024 methylphenidate hydrochloride Tablet, modified release 27 mg Resolved Available Manufacturing 16/10/2024 daptomycin Inhalation, powder for 350 mg Anticipated Available Manufacturing 16/10/2024 enoxaparin sodium Injection, solution 20 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 16/10/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~41.6 mg Current Unavailable Manufacturing 16/10/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~20.8 mg Resolved Available Manufacturing 16/10/2024 nizatidine Capsule, hard 300 mg Resolved Available Manufacturing 16/10/2024 Tenecteplase Injection, powder for 50 mg Resolved Available Unexpected increase in consumer demand 16/10/2024 sodium pertechnetate(99mTc) Injection 370 GBq Resolved Available Manufacturing 16/10/2024 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Anticipated Available Manufacturing 16/10/2024 nizatidine Capsule 150 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 16/10/2024 nizatidine Capsule, hard 300 mg Resolved Available Manufacturing 16/10/2024 acetylcholine chloride Solution, powder for irrigation 10 mg/mL Current Unavailable Manufacturing 15/10/2024 daunorubicin Injection, solution 20 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 15/10/2024 anidulafungin Injection, powder for 100 mg Current Limited Availability Manufacturing 15/10/2024 mycophenolate mofetil Tablet, film coated 500 mg Current Limited Availability Manufacturing 15/10/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Limited Availability Manufacturing 15/10/2024 Digoxinspecific antibody fragment F(ab) (Ovine) Injection, powder for 40 mg Anticipated Available Manufacturing 15/10/2024 duloxetine hydrochloride Capsule, enteric 33.66 mg Current Unavailable Unexpected increase in consumer demand 15/10/2024 escitalopram oxalate Tablet, film coated 12.74 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 15/10/2024 escitalopram oxalate Tablet, film coated 25.47 mg Current Unavailable Manufacturing 15/10/2024 rizatriptan benzoate Tablet, orally disintegrating 14.53 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 15/10/2024 Follitropin alfa Injection, solution 75 IU Current Limited Availability Manufacturing 15/10/2024 atorvastatin calcium trihydrate Tablet, film coated 86.76 mg Resolved Available Manufacturing 15/10/2024 cinacalcet hydrochloride Tablet 99.191 mg Current Limited Availability Manufacturing 15/10/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 15/10/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Unexpected increase in consumer demand 15/10/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 15/10/2024 prasugrel Tablet, film coated 5 mg Current Unavailable Manufacturing 15/10/2024 prasugrel Tablet, film coated 10 mg Current Limited Availability Manufacturing 15/10/2024 estradiol Drug delivery system, transdermal .585 mg Current Unavailable Manufacturing 15/10/2024 estradiol Drug delivery system, transdermal 1.17 mg Current Unavailable Manufacturing 15/10/2024 flecainide acetate Tablet 50 mg Current Unavailable Manufacturing 15/10/2024 pegcetacoplan Injection, solution 1080 mg Resolved Available Manufacturing 15/10/2024 rocuronium bromide Injection, solution 10 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 15/10/2024 estradiol~norethisterone acetate Drug delivery system, transdermal .62 mg~2.7 mg Resolved Available Manufacturing 15/10/2024 pimecrolimus Cream 10 mg/g Resolved Available Manufacturing 15/10/2024 clarithromycin Tablet, film coated 250 mg Anticipated Available Unexpected increase in consumer demand 15/10/2024 griseofulvin Tablet, uncoated 125 mg Resolved Available Manufacturing 14/10/2024 olsalazine sodium Capsule 250 mg Current Unavailable Manufacturing 14/10/2024 iopromide Injection, solution 498.72 mg/mL Current Unavailable Unexpected increase in consumer demand 14/10/2024 telmisartan~hydrochlorothiazide Tablet, film coated 80 mg~12.5 mg Current Limited Availability Manufacturing 14/10/2024 esomeprazole magnesium dihydrate Tablet, enteric coated 21.75 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 14/10/2024 benzathine benzylpenicillin tetrahydrate Injection, suspension 600000 USP Unit Current Unavailable Manufacturing 14/10/2024 oseltamivir phosphate Capsule, hard 98.524 mg Anticipated Available Unexpected increase in consumer demand 14/10/2024 thiotepa Injection, powder for 15 mg Anticipated Available Commercial Changes / Commercial viability 14/10/2024 betahistine dihydrochloride Tablet 16 mg Resolved Available Unexpected increase in consumer demand 14/10/2024 cisplatin Injection, solution 1 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 14/10/2024 olsalazine sodium Tablet, uncoated 500 mg Current Unavailable Manufacturing 14/10/2024 clarithromycin Tablet, film coated 250 mg Current Limited Availability Manufacturing 11/10/2024 primidone Tablet, uncoated 250 mg Current Limited Availability Manufacturing 11/10/2024 neostigmine methylsulfate Injection, solution 2.5 mg Anticipated Available Manufacturing 11/10/2024 tadalafil Tablet 5 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 11/10/2024 tadalafil Tablet, film coated 5 mg Resolved Available Manufacturing 11/10/2024 heparin sodium Injection, solution 5000 IU/mL Current Limited Availability Manufacturing 11/10/2024 midazolam Injection, solution 5 mg/mL Resolved Available Manufacturing 11/10/2024 metoprolol succinate Tablet, modified release 190 mg Anticipated Available Manufacturing 10/10/2024 bisoprolol fumarate Tablet 5 mg Current Unavailable Manufacturing 10/10/2024 nebivolol hydrochloride Tablet 1.363 mg Anticipated Available Manufacturing 10/10/2024 - 2024.10.10
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated atropine sulfate monohydrate Injection, solution 1.2 mg/mL Resolved Available Manufacturing 9/10/2024 acetylcysteine Injection, concentrated 2 g Anticipated Available Manufacturing 9/10/2024 trandolapril Capsule 2 mg Resolved Available Transport / Logistic issues / Storage capacity issues 9/10/2024 isosorbide dinitrate Tablet, uncoated 5 mg Current Limited Availability Manufacturing 9/10/2024 morphine hydrochloride trihydrate Oral Liquid, solution 1 mg/mL Resolved Available Commercial Changes / Commercial viability 9/10/2024 risperidone Tablet, film coated 1 mg Current Unavailable Manufacturing 9/10/2024 acetylcysteine Injection, concentrated 2 g Current Limited Availability Transport / Logistic issues / Storage capacity issues 9/10/2024 galantamine hydrobromide Capsule, modified release 30.756 mg Anticipated Available Manufacturing 9/10/2024 adrenaline (epinephrine) acid tartrate Injection, solution 182 microgram/mL Current Unavailable Manufacturing 9/10/2024 citalopram hydrobromide Tablet, film coated 49.98 mg Anticipated Available Manufacturing 9/10/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Manufacturing 9/10/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 9/10/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 9/10/2024 adrenaline (epinephrine) acid tartrate Injection, solution 1.819 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 9/10/2024 metformin hydrochloride Tablet, film coated 850 mg Resolved Available Manufacturing 9/10/2024 lacosamide Tablet, film coated 100 mg Resolved Available Manufacturing 9/10/2024 codeine phosphate hemihydrate~doxylamine succinate~paracetamol Tablet, uncoated 30 mg~5 mg~450 mg Resolved Available Manufacturing 9/10/2024 amlodipine besilate~hydrochlorothiazide~olmesartan medoxomil Tablet, film coated 6.95 mg~12.5 mg~40 mg Current Unavailable Manufacturing 9/10/2024 calcium chloride dihydrate~magnesium chloride hexahydrate~sodium lactate~glucose~sodium chloride Solution, irrigation 183 mg/L~50.8 mg/L~4.48 g/L~15 g/L~5.38 g/L Current Limited Availability Manufacturing 8/10/2024 calcium chloride dihydrate~glucose~sodium lactate~magnesium chloride hexahydrate~sodium chloride Solution, irrigation 183 mg/L~25 g/L~4.48 g/L~50.8 mg/L~5.38 g/L Current Limited Availability Manufacturing 8/10/2024 levetiracetam Tablet, film coated 500 mg Resolved Available Transport / Logistic issues / Storage capacity issues 8/10/2024 codeine phosphate hemihydrate~doxylamine succinate~paracetamol Tablet, uncoated 10 mg~5.1 mg~500 mg Current Unavailable Manufacturing 8/10/2024 paclitaxel Injection, concentrated 300 mg Current Unavailable Manufacturing 8/10/2024 milrinone Injection, concentrated 10 mg Current Limited Availability Manufacturing 8/10/2024 azithromycin dihydrate Tablet, film coated 524 mg Current Unavailable Manufacturing 8/10/2024 cisplatin Injection, concentrated 1 mg/mL Anticipated Available Manufacturing 8/10/2024 lacosamide Tablet, film coated 150 mg Current Unavailable Manufacturing 8/10/2024 gliclazide Tablet, uncoated 80 mg Resolved Available Unexpected increase in consumer demand 8/10/2024 ketorolac trometamol Injection, solution 30 mg/mL Resolved Available Manufacturing 8/10/2024 phentermine hydrochloride Tablet, modified release 49.7 mg Current Limited Availability Manufacturing 8/10/2024 carmustine Injection, powder for 100 mg Current Unavailable Manufacturing 8/10/2024 methotrexate Tablet 10 mg Current Limited Availability Manufacturing 8/10/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 109 mg Current Unavailable Manufacturing 8/10/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 54.5 mg Current Unavailable Manufacturing 8/10/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 27.25 mg Current Unavailable Manufacturing 8/10/2024 Adalimumab Injection, solution 40 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 8/10/2024 levothyroxine sodium Tablet, uncoated .05 mg Current Unavailable Manufacturing 8/10/2024 cisplatin Injection, solution 1 mg/mL Resolved Available Unexpected increase in consumer demand 8/10/2024 verapamil hydrochloride Tablet, modified release 180 mg Current Limited Availability Manufacturing 8/10/2024 rifabutin Capsule, hard 150 mg Resolved Available Manufacturing 8/10/2024 rizatriptan benzoate Wafer 14.53 mg Resolved Available Manufacturing 8/10/2024 pamidronate disodium Injection, concentrated 6 mg Current Limited Availability Manufacturing 8/10/2024 doxorubicin hydrochloride Injection, concentrated 2 mg/mL Resolved Available Manufacturing 8/10/2024 pegcetacoplan Injection, solution 1080 mg Anticipated Available Manufacturing 7/10/2024 duloxetine hydrochloride Capsule, enteric 33.7 mg Discontinued Unavailable Commercial Changes / Commercial viability 4/10/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Discontinued Unavailable Commercial Changes / Commercial viability 4/10/2024 medronic acid Injection, powder for 10 mg Anticipated Available Manufacturing 4/10/2024 fluoxetine hydrochloride Capsule, hard 22.36 mg Discontinued Unavailable Commercial Changes / Commercial viability 4/10/2024 Liraglutide Injection, solution 6 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 4/10/2024 adrenaline (epinephrine) Injection, solution 1 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 4/10/2024 Choriogonadotropin alfa Injection, solution 250 microgram Current Emergency Supply Only Unexpected increase in consumer demand 4/10/2024 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 8 mg Current Limited Availability Manufacturing 4/10/2024 topotecan hydrochloride Injection, concentrated 4.346 mg Current Unavailable Manufacturing 4/10/2024 Rabies virus Powder 3.25 IU Resolved Available Unexpected increase in demand due to other sponsors unable to supply 4/10/2024 sumatriptan succinate Tablet, film coated 140 mg Current Limited Availability Manufacturing 3/10/2024 midazolam Injection, solution 5 mg Current Limited Availability Manufacturing 3/10/2024 tamsulosin hydrochloride~dutasteride Capsule, modified release 400 microgram~500 microgram Current Limited Availability Manufacturing 3/10/2024 clonidine hydrochloride Tablet, uncoated 100 microgram Current Limited Availability Manufacturing 3/10/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Current Unavailable Manufacturing 3/10/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Unavailable Manufacturing 3/10/2024 telmisartan~hydrochlorothiazide Tablet, film coated 80 mg~12.5 mg Current Limited Availability Manufacturing 3/10/2024 quetiapine fumarate Tablet, film coated 28.78 mg Current Limited Availability Manufacturing 3/10/2024 metformin hydrochloride Tablet, modified release 1000 mg Current Limited Availability Manufacturing 3/10/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 3/10/2024 betahistine dihydrochloride Tablet 16 mg Resolved Available Manufacturing 3/10/2024 potassium clavulanate~amoxicillin trihydrate Tablet, film coated 148.875 mg~1006.25 mg Resolved Available Manufacturing 3/10/2024 clonidine hydrochloride Tablet 100 microgram Resolved Available Unexpected increase in consumer demand 3/10/2024 tenofovir disoproxil fumarate~emtricitabine Tablet, film coated 300 mg~200 mg Current Unavailable Manufacturing 3/10/2024 cinacalcet hydrochloride Tablet 99.191 mg Current Limited Availability Manufacturing 3/10/2024 celecoxib Capsule, hard 100 mg Current Limited Availability Manufacturing 3/10/2024 apomorphine hydrochloride hemihydrate Injection, solution 10 mg Current Limited Availability Manufacturing 3/10/2024 lacosamide Tablet, film coated 100 mg Current Unavailable Manufacturing 3/10/2024 eftrenonacog alfa Injection, powder for 4000 IU Resolved Available Manufacturing 3/10/2024 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Anticipated Available Manufacturing 3/10/2024 trimethoprim Tablet, uncoated 300 mg Anticipated Available Manufacturing 3/10/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 3/10/2024 indometacin Capsule, hard 25 mg Current Unavailable Manufacturing 3/10/2024 mycophenolate mofetil Suspension 200 mg/mL Resolved Available Manufacturing 3/10/2024 levothyroxine sodium Tablet, uncoated .075 mg Current Unavailable Manufacturing 3/10/2024 levothyroxine sodium Tablet, uncoated .2 mg Current Unavailable Manufacturing 3/10/2024 estradiol hemihydrate Drug delivery system, transdermal 1.54 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 3/10/2024 imipramine hydrochloride Tablet, sugar coated 25 mg Current Unavailable Manufacturing 3/10/2024 estradiol hemihydrate Drug delivery system, transdermal .77 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 3/10/2024 estradiol hemihydrate Drug delivery system, transdermal 3.09 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 3/10/2024 celecoxib Capsule, hard 100 mg Resolved Available Manufacturing 3/10/2024 norethisterone acetate~estradiol Drug delivery system, transdermal 2.7 mg~.62 mg Current Unavailable Manufacturing 3/10/2024 amoxicillin trihydrate Tablet, film coated 1148 mg Resolved Available Manufacturing 3/10/2024 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Anticipated Available Manufacturing 3/10/2024 nizatidine Capsule 150 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 3/10/2024 lisinopril dihydrate Tablet, uncoated 10.89 mg Resolved Available Manufacturing 2/10/2024 escitalopram oxalate Tablet, film coated 25.56 mg Resolved Available Manufacturing 2/10/2024 topiramate Tablet, film coated 200 mg Anticipated Available Manufacturing 2/10/2024 zolpidem tartrate Tablet, film coated 10 mg Anticipated Available Manufacturing 2/10/2024 isoniazid Tablet, uncoated 100 mg Resolved Available Manufacturing 2/10/2024 ciprofloxacin hydrochloride Tablet, film coated 832.5 mg Anticipated Available Manufacturing 2/10/2024 gliclazide Tablet, modified release 30 mg Anticipated Available Manufacturing 2/10/2024 silver sulfadiazine Cream 10 mg/g Current Unavailable Manufacturing 2/10/2024 silver sulfadiazine Cream 10 mg/g Current Limited Availability Manufacturing 2/10/2024 risperidone Tablet, film coated 4 mg Anticipated Available Manufacturing 2/10/2024 donepezil hydrochloride Tablet, film coated 5 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 2/10/2024 hydrocortisone sodium succinate Injection, powder for 334.25 mg Current Limited Availability Manufacturing 2/10/2024 bicalutamide Tablet, film coated 50 mg Anticipated Available Manufacturing 2/10/2024 quetiapine fumarate Tablet, film coated 115.12 mg Resolved Available Manufacturing 2/10/2024 quetiapine fumarate Tablet, film coated 345.36 mg Current Limited Availability Manufacturing 2/10/2024 simvastatin Tablet, film coated 80 mg Anticipated Available Manufacturing 2/10/2024 citalopram hydrobromide Tablet, film coated 49.98 mg Anticipated Available Manufacturing 2/10/2024 fluorouracil Injection, solution 50 mg/mL Current Limited Availability Manufacturing 2/10/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 2/10/2024 atomoxetine hydrochloride Capsule, hard 45.5 mg Current Unavailable Manufacturing 2/10/2024 fluconazole Capsule, hard 200 mg Anticipated Available Manufacturing 2/10/2024 phenytoin sodium Capsule, hard 100 mg Resolved Available Manufacturing 2/10/2024 lacosamide Tablet, film coated 50 mg Anticipated Available Manufacturing 2/10/2024 risperidone Oral Liquid, solution 1 mg/mL Resolved Available Manufacturing 2/10/2024 teriflunomide Tablet, film coated 14 mg Anticipated Available Manufacturing 2/10/2024 pregabalin Capsule, hard 75 mg Anticipated Available Manufacturing 2/10/2024 pregabalin Capsule, hard 75 mg Anticipated Available Manufacturing 2/10/2024 methylphenidate hydrochloride Tablet, modified release 54 mg Current Unavailable Manufacturing 2/10/2024 captopril Tablet, uncoated 25 mg Resolved Available Manufacturing 2/10/2024 captopril Tablet, uncoated 50 mg Resolved Available Manufacturing 2/10/2024 indapamide hemihydrate Tablet 2.5 mg Resolved Available Manufacturing 2/10/2024 metformin hydrochloride Tablet, film coated 1000 mg Resolved Available Manufacturing 2/10/2024 rasagiline mesilate Tablet 1.56 mg Current Limited Availability Manufacturing 1/10/2024 Rabies virus Injection, powder for 2.5 IU Resolved Available Manufacturing 1/10/2024 prasugrel Tablet, film coated 10 mg Current Limited Availability Manufacturing 1/10/2024 spironolactone Tablet, uncoated 100 mg Resolved Available Manufacturing 1/10/2024 sugammadex sodium Injection, solution 217.6 mg Resolved Available Commercial Changes / Commercial viability 1/10/2024 Follitropin beta Injection, solution 833 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 1/10/2024 clonidine hydrochloride Tablet, uncoated 150 microgram Current Limited Availability Manufacturing 1/10/2024 Peginterferon alfa2a Injection, solution 135 microgram Anticipated Available Unexpected increase in consumer demand 1/10/2024 Peginterferon alfa2a Injection, solution 180 microgram Anticipated Available Unexpected increase in consumer demand 1/10/2024 pimecrolimus Cream 10 mg/g Current Limited Availability Manufacturing 1/10/2024 griseofulvin Tablet, uncoated 125 mg Current Unavailable Manufacturing 30/09/2024 sodium pyrophosphate Injection, powder for 30 mg Current Limited Availability Manufacturing 30/09/2024 hydrocortisone sodium succinate Injection, powder for 134 mg Resolved Available Manufacturing 30/09/2024 cefepime hydrochloride monohydrate Injection, powder for 1189.2 mg Anticipated Available Manufacturing 30/09/2024 lacosamide Tablet, film coated 100 mg Current Limited Availability Commercial Changes / Commercial viability 30/09/2024 lacosamide Tablet, film coated 150 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 30/09/2024 heparin sodium Injection, solution 5000 IU/mL Current Limited Availability Manufacturing 30/09/2024